<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Multiple Sclerosis on VitaminDWiki</title><link>/categories/multiple-sclerosis.html</link><description>Recent content in Multiple Sclerosis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Mon, 06 Mar 2017 00:00:00 +0000</lastBuildDate><atom:link href="/categories/multiple-sclerosis/index.xml" rel="self" type="application/rss+xml"/><item><title>Multiple Sclerosis - subtle early signs – should probably take vitamin D</title><link>/posts/multiple-sclerosis-subtle-early-signs-should-probably-take-vitamin-d.html</link><pubDate>Mon, 06 Mar 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-subtle-early-signs-should-probably-take-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis is more likely if poor Vitamin D Receptor (4X Mexico, 3X Iran)</title><link>/posts/multiple-sclerosis-is-more-likely-if-poor-vitamin-d-receptor-4x-mexico-3x-iran.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-more-likely-if-poor-vitamin-d-receptor-4x-mexico-3x-iran.html</guid><description/></item><item><title>Off Topic: Some disabled people (MS, Parkinson, blind, deaf etc) are using second life</title><link>/posts/off-topic-some-disabled-people-ms-parkinson-blind-deaf-etc-are-using-second-life.html</link><pubDate>Tue, 28 Feb 2017 00:00:00 +0000</pubDate><guid>/posts/off-topic-some-disabled-people-ms-parkinson-blind-deaf-etc-are-using-second-life.html</guid><description>&lt;h4 id="great-articlehttpsbackchannelcomfirst-they-got-sick-then-they-moved-into-a-virtual-utopia-1dc6c165f3e9pia9rk6v620">&lt;a href="https://backchannel.com/first-they-got-sick-then-they-moved-into-a-virtual-utopia-1dc6c165f3e9#.pia9rk6v6%20">Great article&lt;/a>&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>800,000 users each month&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Second Life has many disability groups&lt;/p>
&lt;/li>
&lt;li>
&lt;p>The Virtual Ability group has thousand members, and hosts a dozen or so events per week, including games, live piano concerts, dance parties and self-help workshops&lt;/p>
&lt;/li>
&lt;li>
&lt;p>For some of the people the experiencing of a virtual ability results in an improved ability in real life&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h3 id="httpsecondlifecomhttpsecondlifecom">&lt;a href="http://secondlife.com/">http://secondlife.com/&lt;/a>&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/second-life.jpg" alt="image" width="500"></description></item><item><title>Multiple Sclerosis Relapsing-Remitting rate reduced 30 percent by addition of 14,000 IU vitamin D daily – RCT</title><link>/posts/multiple-sclerosis-relapsing-remitting-rate-reduced-30-percent-by-addition-of-14-min-d-daily-rct.html</link><pubDate>Sat, 21 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapsing-remitting-rate-reduced-30-percent-by-addition-of-14-min-d-daily-rct.html</guid><description>&lt;h4 id="a-phase-ii-study-of-the-efficacy-and-safety-of-high-dose-cholecalciferol-vitamin-d3-oil-as-add-on-therapy-in-subjects-with-relapsing-remitting-multiple-sclerosis-receiving-subcutaneous-interferon-β-1a-solar">A Phase II Study of the Efficacy and Safety of High-Dose Cholecalciferol (Vitamin D3) Oil as Add-on Therapy in Subjects with Relapsing-Remitting Multiple Sclerosis Receiving Subcutaneous Interferon β-1a: SOLAR&lt;/h4>
&lt;p>J. Smolders1,2, R. Hupperts1, R. Vieth3, T. Holmøy4, K. Marhardt5, M. Schluep6, J. Killestein7, F. Barkhof7,8, L.M.E. Grimaldi9, M. Beelke10&lt;/p>
&lt;p>&lt;strong>Poster presented at Presented at European Charcot Foundation (ECF) 2016; November 24–28, 2016; Baveno, Italy&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/ms-helped-by-14-000-iu-daily.pdf">Download the PDF-Poster from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Doctor got multiple sclerosis, rejected then embraced Coimbra protocol for herself and patients</title><link>/posts/doctor-got-multiple-sclerosis-rejected-then-embraced-coimbra-protocol-for-herself-and-patients.html</link><pubDate>Thu, 19 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/doctor-got-multiple-sclerosis-rejected-then-embraced-coimbra-protocol-for-herself-and-patients.html</guid><description/></item><item><title>Mendelian proof that low vitamin D (due to 3 genes) increase risk of MS by 20 percent</title><link>/posts/mendelian-proof-that-low-vitamin-d-due-to-3-genes-increase-risk-of-ms-by-20-percent.html</link><pubDate>Sun, 15 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/mendelian-proof-that-low-vitamin-d-due-to-3-genes-increase-risk-of-ms-by-20-percent.html</guid><description/></item><item><title>Multiple Sclerosis and Vitamin D ~ 50,000 Facebook members in 13 languages</title><link>/posts/multiple-sclerosis-and-vitamin-d-50000-facebook-members-in-13-languages.html</link><pubDate>Tue, 10 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-50000-facebook-members-in-13-languages.html</guid><description>&lt;h4 id="coimbra">Coimbra&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="https://www.google.com/maps/d/u/0/viewer?mid=1fATZJUEhOsYYJdBY41h48FBkLaQ&amp;amp;ll=19.192120392882064%2C-24.66098360000003&amp;amp;z=2">Google Map of Doctors&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol">Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol - Feb 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016">Interview and transcript: Vitamin D protocol for Autoimmune diseases – Dr. Coimbra 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-is-the-real-multiple-sclerosis-therapy-not-an-alternative-therapy-coimbra" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D is the real Multiple Sclerosis Therapy, not an alternative therapy – Coimbra July 2018">Vitamin D is the real Multiple Sclerosis Therapy, not an alternative therapy – Coimbra July 2018&lt;/a>&lt;/p></description></item><item><title>Autoimmune risk gene ZMIZ1 is associated with both MS and Vitamin D</title><link>/posts/autoimmune-risk-gene-zmiz1-is-associated-with-both-ms-and-vitamin-d.html</link><pubDate>Thu, 05 Jan 2017 00:00:00 +0000</pubDate><guid>/posts/autoimmune-risk-gene-zmiz1-is-associated-with-both-ms-and-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis relapse in children is twice as likely having a Vitamin D Gene score of 6</title><link>/posts/multiple-sclerosis-relapse-in-children-is-twice-as-likely-having-a-vitamin-d-gene-score-of-6.html</link><pubDate>Thu, 22 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-relapse-in-children-is-twice-as-likely-having-a-vitamin-d-gene-score-of-6.html</guid><description/></item><item><title>Multiple sclerosis risk factors include vitamin D</title><link>/posts/multiple-sclerosis-risk-factors-include-vitamin-d.html</link><pubDate>Sun, 11 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-include-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis suppressed by an Ultraviolet wavelength not associated with Vitamin D (mice)</title><link>/posts/multiple-sclerosis-suppressed-by-an-ultraviolet-wavelength-not-associated-with-vitamin-d-mice.html</link><pubDate>Sat, 03 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-suppressed-by-an-ultraviolet-wavelength-not-associated-with-vitamin-d-mice.html</guid><description/></item><item><title>A gestational dose of vitamin D per day keeps the MS doctor away (2X reduction)</title><link>/posts/a-gestational-dose-of-vitamin-d-per-day-keeps-the-ms-doctor-away-2x-reduction.html</link><pubDate>Fri, 02 Dec 2016 00:00:00 +0000</pubDate><guid>/posts/a-gestational-dose-of-vitamin-d-per-day-keeps-the-ms-doctor-away-2x-reduction.html</guid><description/></item><item><title>Multiple Sclerosis Conference had scores of Vitamin D presentations</title><link>/posts/multiple-sclerosis-conference-had-scores-of-vitamin-d-presentations.html</link><pubDate>Fri, 30 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-conference-had-scores-of-vitamin-d-presentations.html</guid><description/></item><item><title>Interview and transcript: Vitamin D protocol for Autoimmune diseases – Dr. Coimbra 2016</title><link>/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016.html</link><pubDate>Wed, 28 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/interview-and-transcript-vitamin-d-protocol-for-autoimmune-diseases-dr-coimbra-2016.html</guid><description/></item><item><title>Multiple Sclerosis much more likely if poor Vitamin D Receptor – several studies</title><link>/posts/multiple-sclerosis-much-more-likely-if-poor-vitamin-d-receptor-several-studies.html</link><pubDate>Mon, 26 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-much-more-likely-if-poor-vitamin-d-receptor-several-studies.html</guid><description>&lt;h4 id="vitamin-d-receptor-gene-polymorphisms-are-associated-with-multiple-sclerosis-in-mexican-adults---may-2017">Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults - May 2017&lt;/h4>
&lt;p>Journal of Neuroimmunology, Volume 306, 15 May 2017, Pages 20–24, &lt;a href="https://doi.org/10.1016/j.jneuroim.2017.01.009">https://doi.org/10.1016/j.jneuroim.2017.01.009&lt;/a>&lt;/p>
&lt;p>Víctor Hugo Bermúdez-Moralesa, Geny Fierrosa, Roberto Lopez Lopeza, Gaby Martínez-Navaa, Mario Flores-Aldanab, José Flores-Riverac, Carlos Hernández-Girónd, ,&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Multiple sclerosis (MS) is the most prevalent autoimmune inflammatory demyelinating disease of the central nervous system (CNS) in young adults. More than 50 genomic regions have been associated with MS susceptibility.&lt;/p></description></item><item><title>Multiple Sclerosis and small doses of Vitamin D – meta-review</title><link>/posts/multiple-sclerosis-and-small-doses-of-vitamin-d-meta-review.html</link><pubDate>Wed, 07 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-small-doses-of-vitamin-d-meta-review.html</guid><description>&lt;ul>
&lt;li>
&lt;p>They consider &amp;gt;1,000 IU to be “high dose”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>For MS high dose should be 20X higher&lt;/p>
&lt;/li>
&lt;/ul>
&lt;ol>
&lt;li>
&lt;p>More than one nutrient is used by Dr. Coimbra&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Dose size varies with the patient (not one size fits all)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>No randomized controlled trials for Dr. Coimbra – all patients are treated, not just half&lt;/p>
&lt;/li>
&lt;/ol>
&lt;ul>
&lt;li>They thus gnore the success at CURING &amp;gt; 1,000 MS patients by Dr. Coimbra with Vitamin D, etc.&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>The words Coimbra or Brazil do not occur even once in the meta-review&lt;/p></description></item><item><title>Multiple Sclerosis helped by UV – possibly via cytokines, etc.</title><link>/posts/multiple-sclerosis-helped-by-uv-possibly-via-cytokines-etc.html</link><pubDate>Wed, 07 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-helped-by-uv-possibly-via-cytokines-etc.html</guid><description/></item><item><title>Multiple sclerosis helped some by 10,000 IU of vitamin D daily avg. for 3 months – RCT</title><link>/posts/multiple-sclerosis-helped-some-by-10000-iu-of-vitamin-d-daily-avg-for-3-months-rct.html</link><pubDate>Wed, 07 Sep 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-helped-some-by-10000-iu-of-vitamin-d-daily-avg-for-3-months-rct.html</guid><description/></item><item><title>Multiple sclerosis in children – low vitamin D is a potential factor</title><link>/posts/multiple-sclerosis-in-children-low-vitamin-d-is-a-potential-factor.html</link><pubDate>Wed, 31 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-in-children-low-vitamin-d-is-a-potential-factor.html</guid><description/></item><item><title>Testimonial on curing Multiple Sclerosis with 20,000 IU of vitamin D</title><link>/posts/testimonial-on-curing-multiple-sclerosis-with-20000-iu-of-vitamin-d.html</link><pubDate>Tue, 23 Aug 2016 00:00:00 +0000</pubDate><guid>/posts/testimonial-on-curing-multiple-sclerosis-with-20000-iu-of-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis and obesity share some gene problems (as well as low vitamin D)</title><link>/posts/multiple-sclerosis-and-obesity-share-some-gene-problems-as-well-as-low-vitamin-d.html</link><pubDate>Thu, 30 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-obesity-share-some-gene-problems-as-well-as-low-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis – one person’s benefit of Vitamin D protocol by Dr. Coimbra</title><link>/posts/multiple-sclerosis-one-persons-benefit-of-vitamin-d-protocol-by-dr-coimbra.html</link><pubDate>Wed, 22 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-one-persons-benefit-of-vitamin-d-protocol-by-dr-coimbra.html</guid><description>&lt;p>&lt;strong>The following is translated from Portuguese on &lt;a href="https://www.facebook.com/groups/EscleroseMultiplaOTratamento/permalink/1201611816550711/%20">Facebook&lt;/a> June 2016&lt;/strong>&lt;/p>
&lt;p>This is Daniel Cunha, a journalist who has MS and has &lt;strong>produced the video &amp;quot; Vitamin D - for an alternative therapy.&amp;quot;&lt;/strong> Daniel has been on the Coimbra protocol for 6 years and this is an update on how his treatment is progressing.&lt;/p>
&lt;p>&amp;ldquo;My name is Daniel Cunha, I&amp;rsquo;m 30 years old and was diagnosed with MS at the end of 2009 after a major flare up, with a variety of neurological symptoms. I was admitted to the hospital, took corticoids and recovered completely after about a month and a half.&lt;/p></description></item><item><title>Multiple Sclerosis 60 percent less likely in those with more than 40 ng of vitamin D – 2006</title><link>/posts/multiple-sclerosis-60-percent-less-likely-in-those-with-more-than-40-ng-of-vitamin-d-2006.html</link><pubDate>Fri, 10 Jun 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-60-percent-less-likely-in-those-with-more-than-40-ng-of-vitamin-d-2006.html</guid><description/></item><item><title>Multiple Sclerosis 2X more likely if vitamin D deficient as a fetus decades earlier</title><link>/posts/multiple-sclerosis-2x-more-likely-if-vitamin-d-deficient-as-a-fetus-decades-earlier.html</link><pubDate>Tue, 10 May 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-2x-more-likely-if-vitamin-d-deficient-as-a-fetus-decades-earlier.html</guid><description/></item><item><title>Multiple Sclerosis associated with low vitamin D – by B-cells which produce antibodies</title><link>/posts/multiple-sclerosis-associated-with-low-vitamin-d-by-b-cells-which-produce-antibodies.html</link><pubDate>Fri, 29 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-associated-with-low-vitamin-d-by-b-cells-which-produce-antibodies.html</guid><description/></item><item><title>Vitamin D should be taken by all MS patients - Consortium of Multiple Sclerosis Centres</title><link>/posts/vitamin-d-should-be-taken-by-all-ms-patients-consortium-of-multiple-sclerosis-centres.html</link><pubDate>Tue, 26 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-should-be-taken-by-all-ms-patients-consortium-of-multiple-sclerosis-centres.html</guid><description>&lt;h3 id="experts-agree-on-vitamin-d-benefits-260416httpwwwms-ukorgapr37">&lt;a href="http://www.ms-uk.org/apr37">Experts agree on vitamin D benefits (26/04/16)&lt;/a>&lt;/h3>
&lt;p>&lt;strong>snips&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&amp;ldquo;There is, therefore, little doubt that vitamin D provides a range of valuable health effects — effects of importance to everyone, but of particular importance to people with MS.&amp;rdquo;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;lsquo;Studies showed that children who have lower vitamin D levels more often develop MS as adults.&amp;quot;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&amp;ldquo;To really conclude that vitamin D impacts the disease, randomized prospective clinical trials are needed. One such trial, the VIDAMS study, is currently underway. The study explores if high-dose supplements — 5000 IU per day . . . &amp;quot;&lt;/p></description></item><item><title>Multiple Sclerosis - low vitamin D, low sun, smoking are the largest modifiable factors</title><link>/posts/multiple-sclerosis-low-vitamin-d-low-sun-smoking-are-the-largest-modifiable-factors.html</link><pubDate>Sat, 09 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-low-vitamin-d-low-sun-smoking-are-the-largest-modifiable-factors.html</guid><description>&lt;h4 id="factors-associated-with-onset-relapses-or-progression-in-multiple-sclerosis-a-systematic-review">Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review&lt;/h4>
&lt;p>NeuroToxicology, April 2016, doi:10.1016/j.neuro.2016.03.020 &lt;strong>78 pages&lt;/strong>&lt;/p>
&lt;p>Kyla A. McKaya, Shayesteh Jahanfarb, Tom Duggana, Stacey Tkachuka, Helen Tremletta &lt;a href="mailto:helen.tremlett@ubc.ca">helen.tremlett@ubc.ca&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is a chronic disease of the central nervous system with an unidentified etiology. We systematically reviewed the literature on the possible risk factors associated with MS disease onset, relapses and progression from 1960-2012 by accessing six databases and including relevant&lt;/p></description></item><item><title>10 Diseases associated with Multiple Sclerosis are also associated with low Omega-3 and vitamin D</title><link>/posts/10-diseases-associated-with-multiple-sclerosis-are-also-associated-with-low-omega-3-and-vitamin-d.html</link><pubDate>Sun, 13 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/10-diseases-associated-with-multiple-sclerosis-are-also-associated-with-low-omega-3-and-vitamin-d.html</guid><description>&lt;h4 id="multiple-sclerosis---a-lifestyle-disease">Multiple sclerosis - A lifestyle disease?&lt;/h4>
&lt;p>Neurology Journal Editorial doi:http:/​/​dx.​doi.​org/​10.​1212/​WNL.​0000000000002487&lt;/p>
&lt;p>William B. Grant, PhD and Trond Riise, PhD&lt;/p>
&lt;p>&lt;strong>Publisher provided Free Excerpt&lt;/strong>&lt;/p>
&lt;p>Chronic diseases are the primary cause of disability, morbidity, and death in Western developed countries. Many of these diseases are related to environmental influences including diet, smoking, and other lifestyle factors. Public health measures address some of these factors, and studies strengthening the links between environmental factors and health can be useful in this regard.&lt;/p></description></item><item><title>Multiple Sclerosis and (lots of) Vitamin D - book by patient on Coimbra protocol</title><link>/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol.html</link><pubDate>Wed, 09 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-lots-of-vitamin-d-book-by-patient-on-coimbra-protocol.html</guid><description>&lt;h4 id="video-by-a-coimbra-patient">Video by a Coimbra Patient&lt;/h4>
&lt;p>&lt;a href="https://www.youtube.com/watch?v=Mb8mJ-L16Ik&amp;amp;feature=share">March 2015, 6 minutes&lt;/a>&lt;/p>
&lt;p>In Portuguese with English Captions&lt;/p>
&lt;hr>
&lt;h4 id="coimbra-protocol-in-spanish">Coimbra Protocol in Spanish&lt;/h4>
&lt;p>&lt;a href="http://www.tengoesclerosismultiple.com/">http://www.tengoesclerosismultiple.com/&lt;/a>&lt;/p>
&lt;p>&lt;strong>Short URL =&lt;/strong> is.gd/domene&lt;/p></description></item><item><title>Multiple Sclerosis much more likely if low vitamin D during pregnancy –many studies</title><link>/posts/multiple-sclerosis-much-more-likely-if-low-vitamin-d-during-pregnancy-many-studies.html</link><pubDate>Mon, 07 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-much-more-likely-if-low-vitamin-d-during-pregnancy-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#meta-analysis-found-40-more-likely-for-offspring-to-develop-ms-if-low-vitamin-d-during-pregnancy---jan-2020">Meta-analysis found 40% more likely for offspring to develop MS if low Vitamin D during pregnancy - Jan 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosis-19x-more-likely-if-low-vitamin-d-during-pregnancy--march-2016">Multiple Sclerosis 1.9X more likely if low vitamin D during pregnancy – March 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="meta-analysis-found-40-more-likely-for-offspring-to-develop-ms-if-low-vitamin-d-during-pregnancy---jan-2020">Meta-analysis found 40% more likely for offspring to develop MS if low Vitamin D during pregnancy - Jan 2020&lt;/h4>
&lt;p>&lt;strong>Gestational Vitamin D and Offspring Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/pregnancy-ms-meta.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis risk factors – Vitamin D, parasites, and EBV – 2015</title><link>/posts/multiple-sclerosis-risk-factors-vitamin-d-parasites-and-ebv-2015.html</link><pubDate>Tue, 05 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-factors-vitamin-d-parasites-and-ebv-2015.html</guid><description>&lt;h4 id="multiple-sclerosis-and-environmental-factors-the-role-of-vitamin-d-parasites-and-epstein-barr-virus-infection">Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection.&lt;/h4>
&lt;p>Acta Neurol Scand. 2015;132(199):46-55. &lt;a href="https://doi.org/10.1111/ane.12431.">doi: 10.1111/ane.12431.&lt;/a>&lt;/p>
&lt;p>Correale J1, Gaitán MI1.&lt;/p>
&lt;p>1Department of Neurology, Institute for Neurological Research Dr. Raúl Carrea, FLENI, Buenos Aires, Argentina.&lt;/p>
&lt;p>Pathogenic mechanisms underlying multiple sclerosis development have yet to be clearly identified, but considerable evidence indicates that autoimmunity plays an important role in the etiology of the disease. It is generally accepted that autoimmune diseases like MS arise from complex interactions between genetic susceptibility and environmental factors. Although environmental factors unequivocally influencing MS development have yet to be established, accumulating evidence singles out several candidates, including sunlight-UV exposure or vitamin D deficiency, viral infections, hygiene, and cigarette smoking. Vitamin D deficiency has been associated with different autoimmune diseases. Several investigations indicate 125 (OH)2 vitamin D plays a critical role in shaping T-cell response and inducing T cells with immunosuppressive properties. Likewise, helminth infections represent another potential environmental factor exerting immunomodulatory properties. Both epidemiological and experimental data provide evidence to support autoimmune down-regulation secondary to parasite infections in patients with MS, through regulatory T- and B-cell action, with effects extending beyond simple response to an infectious agent. Finally, different epidemiological studies have demonstrated that Epstein-Barr virus infection confers added risk of developing MS. Proposed mechanisms responsible for this association include activation and expansion of self-reactive T and B cells, lower threshold for self-tolerance breakdown, and enhanced autoreactive B-cell survival, all to be discussed in this review. Understanding environmental factors influencing propensity to MS will lead to new and more effective approaches to prevent and treat the disease.&lt;/p></description></item><item><title>Off topic: Cannabis and disease studies at GreenMedInfo</title><link>/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo.html</link><pubDate>Mon, 28 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/off-topic-cannabis-and-disease-studies-at-greenmedinfo.html</guid><description>&lt;h4 id="raw-cannabis-juice-helps-young-woman-ditch-40-medicationshttptvgreenmedinfocomraw-cannabis-juice-helps-young-woman-ditch-40-medications">&lt;a href="http://tv.greenmedinfo.com/raw-cannabis-juice-helps-young-woman-ditch-40-medications/">Raw Cannabis Juice Helps Young Woman Ditch 40 Medications&lt;/a>&lt;/h4>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;p>&lt;strong>Note – There is a BIG difference between cannabis products&lt;/strong>&lt;/p>
&lt;p>Most research - such as in the table below does not distinguish between THC and CBD&lt;/p>
&lt;p>In a nutshell :It appears that&lt;/p>
&lt;p>&lt;strong>| | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; |
| | THC | CBD |
| Benefit | Get high | Pain relief |
| Typical cannabis | 50% | 50% |
| High-grade cannabis | 90% | 10% |
| Pain relief cannabis | 5% | 95% |
| Legal in US states | &amp;lt;10% | 100% |&lt;/strong>&lt;/p></description></item><item><title>Multiple Sclerosis – more gray matter and fewer relapses if 10 ng more vitamin D</title><link>/posts/multiple-sclerosis-more-gray-matter-and-fewer-relapses-if-10-ng-more-vitamin-d.html</link><pubDate>Sat, 31 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-more-gray-matter-and-fewer-relapses-if-10-ng-more-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis vitamin D treatments – update</title><link>/posts/multiple-sclerosis-vitamin-d-treatments-update.html</link><pubDate>Fri, 23 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-vitamin-d-treatments-update.html</guid><description>&lt;h3 id="update-in-vitamin-d-and-multiple-sclerosis">Update in vitamin D and multiple sclerosis.&lt;/h3>
&lt;p>Neurosciences (Riyadh). 2015 Oct;20(4):329-335. &lt;a href="https://doi.org/10.17712/nsj.2015.4.20150357.">doi: 10.17712/nsj.2015.4.20150357.&lt;/a>&lt;/p>
&lt;p>Alharbi FM1.&lt;/p>
&lt;p>1Department of Neurology, College of Medicine, Qassim University, Buraidah, Kingdom of Saudi Arabia. E-mail: &lt;a href="mailto:fatimahali@qumed.edu.sa">fatimahali@qumed.edu.sa&lt;/a>.&lt;/p>
&lt;p>Multiple sclerosis (MS) is a common neurological disease, and its etiology remains unknown. In recent years, increasing attention has been paid to the possible association between MS and vitamin D deficiency. Here, we review the current literature between MS and vitamin D, &lt;strong>showing clear evidence that vitamin D deficiency is a risk factor for MS&lt;/strong> despite the lack of direct evidence for the effects of vitamin D in MS progression.&lt;/p></description></item><item><title>Multiple Sclerosis Treatment and Research -Vitamin D presentations at European Congress</title><link>/posts/multiple-sclerosis-treatment-and-research-vitamin-d-presentations-at-european-congress.html</link><pubDate>Mon, 19 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-treatment-and-research-vitamin-d-presentations-at-european-congress.html</guid><description/></item><item><title>If born in the winter, 11 percent more likely to be vitamin D deficient as an adult</title><link>/posts/if-born-in-the-winter-11-percent-more-likely-to-be-vitamin-d-deficient-as-an-adult.html</link><pubDate>Sun, 27 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/if-born-in-the-winter-11-percent-more-likely-to-be-vitamin-d-deficient-as-an-adult.html</guid><description>&lt;h4 id="birth-season-and-vitamin-d-concentration-in-adulthood">Birth season and vitamin D concentration in adulthood&lt;/h4>
&lt;p>Annals of Translational Medicine, Vol 3, No 16 (September 2015) &lt;a href="https://doi.org/10.3978/j.issn.2305-5839.2015.09.30">doi: 10.3978/j.issn.2305-5839.2015.09.30&lt;/a>&lt;/p>
&lt;p>Giuseppe Lippi &lt;a href="mailto:glippi@ao.pr.it">glippi@ao.pr.it&lt;/a>, Patrizia Bonelli, Ruggero Buonocore, Rosalia Aloe&lt;/p>
&lt;p>Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy&lt;/p>
&lt;p>Contributions: (I) Conception and design: G Lippi; (II) Administrative support: G Lippi, P Bonelli; (III) Provision of study materials or patients: P Bonelli, R Aloe; (IV) Collection and assembly of data: P Bonelli, R Buonocore, R Aloe; (V) Data analysis and interpretation: P Bonelli, R Aloe; (VI) Manuscript writing: G Lippi, P Bonelli, R Aloe; (VII) Final approval of manuscript: G Lippi, P Bonelli, R Aloe.&lt;/p></description></item><item><title>Multiple Sclerosis risk reduced 46 percent by Omega-3 derived from fish (1 gram)</title><link>/posts/multiple-sclerosis-risk-reduced-46-percent-by-omega-3-derived-from-fish-1-gram.html</link><pubDate>Sat, 19 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-risk-reduced-46-percent-by-omega-3-derived-from-fish-1-gram.html</guid><description>&lt;h4 id="higher-intake-of-omega-3-polyunsaturated-fatty-acids-is-associated-with-a-decreased-risk-of-a-first-clinical-diagnosis-of-central-nervous-system-demyelination-results-from-the-ausimmune-study">Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study.&lt;/h4>
&lt;p>Mult Scler. 2015 Sep 11. pii: 1352458515604380. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Hoare S1, Lithander F2, van der Mei I3, Ponsonby AL4, Lucas R5; Ausimmune Investigator Group.&lt;/p>
&lt;p>.1National Centre for Epidemiology and Population Health, The Australian National University, Australia &lt;a href="mailto:samuelhoare7@gmail.com">samuelhoare7@gmail.com&lt;/a>.&lt;/p>
&lt;p>2The University of Canberra, Australia.&lt;/p></description></item><item><title>Vitamin D has already cleared 100 percent of lesions from over 1,000 MS patients in Brazil</title><link>/posts/vitamin-d-has-already-cleared-100-percent-of-lesions-from-over-1000-ms-patients-in-brazil.html</link><pubDate>Sun, 30 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-has-already-cleared-100-percent-of-lesions-from-over-1000-ms-patients-in-brazil.html</guid><description/></item><item><title>Genes make Multiple Sclerosis 2X more likely unless get more vitamin D</title><link>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</link><pubDate>Wed, 26 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/genes-make-multiple-sclerosis-2x-more-likely-unless-get-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#plos-editors-summary">(PLOS) Editors&amp;rsquo; Summary&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-sunlight-snps-with-multiple-sclerosis-susceptibility">Association of SUNLIGHT SNPs with Multiple Sclerosis Susceptibility&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mendelian-randomization-analysis-for-the-association-of-25ohd-with-multiple-sclerosis-risk">Mendelian Randomization Analysis for the Association of 25OHD with Multiple Sclerosis Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#59-references">59 References&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#expert-reaction-to-new-study-on-vitamin-d-deficiency-and-ms">Expert reaction to new study on vitamin D deficiency and MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extensive-positive-comments-on-study-in-neurology-today---sept-2015">Extensive positive comments on study in Neurology Today - Sept 2015&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-and-risk-of-multiple-sclerosis-a-mendelian-randomization-study---2015">Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study - 2015&lt;/h3>
&lt;p>PLOS ONE&lt;/p></description></item><item><title>Dr. Coimbra explains his treatment with high dose vitamin D for multiple sclerosis</title><link>/posts/dr-coimbra-explains-his-treatment-with-high-dose-vitamin-d-for-multiple-sclerosis.html</link><pubDate>Thu, 20 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/dr-coimbra-explains-his-treatment-with-high-dose-vitamin-d-for-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#youtube-videohttpswwwyoutubecomwatchvsokm6z1cdim20">&lt;a href="https://www.youtube.com/watch?v=soKM6z1cdiM%20">YouTube Video&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="youtube-videohttpswwwyoutubecomwatchvsokm6z1cdim20">&lt;a href="https://www.youtube.com/watch?v=soKM6z1cdiM%20">YouTube Video&lt;/a>&lt;/h2>
&lt;p>&lt;strong>Transcript from video&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>0:02My experience has been mostly with higher doses of Vitamin D.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:10Specifically answering the Multiple Sclerosis question,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:15it was around 2002 when we started prescribing 10.000 units of Vitamin D daily to patients with multiple sclerosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:27due to literature data that had already been available, showing that Vitamin D is an immune-regulator,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:37regulating the autoimmune system, and not suppressing it,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:43stimulating the autoimmune system and efficiently helping it fight against infections,&lt;/p></description></item><item><title>Multiple Sclerosis patients need more vitamin D to get same blood level response</title><link>/posts/multiple-sclerosis-patients-need-more-vitamin-d-to-get-same-blood-level-response.html</link><pubDate>Thu, 20 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-need-more-vitamin-d-to-get-same-blood-level-response.html</guid><description/></item><item><title>Multiple Sclerosis web survey: 82 percent take vitamin D (2000-5000 IU), strong association with latitude</title><link>/posts/multiple-sclerosis-web-survey-82-percent-take-vitamin-d-2000-5000-iu-strong-asso-n-with-latitude.html</link><pubDate>Wed, 05 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-web-survey-82-percent-take-vitamin-d-2000-5000-iu-strong-asso-n-with-latitude.html</guid><description/></item><item><title>Vitamin D and multiple sclerosis—from epidemiology to prevention</title><link>/posts/vitamin-d-and-multiple-sclerosisfrom-epidemiology-to-prevention.html</link><pubDate>Fri, 26 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosisfrom-epidemiology-to-prevention.html</guid><description/></item><item><title>No multiple sclerosis relapses during pregnancy if 50,000 IU of Vitamin D weekly – RCT</title><link>/posts/no-multiple-sclerosis-relapses-during-pregnancy-if-50000-iu-of-vitamin-d-weekly-rct.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/no-multiple-sclerosis-relapses-during-pregnancy-if-50000-iu-of-vitamin-d-weekly-rct.html</guid><description/></item><item><title>Multiple Sclerosis incidence rate cut in half by 800 IU of vitamin D in cod liver oil</title><link>/posts/multiple-sclerosis-incidence-rate-cut-in-half-by-800-iu-of-vitamin-d-in-cod-liver-oil.html</link><pubDate>Fri, 08 May 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-incidence-rate-cut-in-half-by-800-iu-of-vitamin-d-in-cod-liver-oil.html</guid><description>&lt;h3 id="timing-of-use-of-cod-liver-oil-a-vitamin-d-source-and-multiple-sclerosis-risk-the-envims-study">Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.&lt;/h3>
&lt;p>Mult Scler. 2015 May 6. pii: 1352458515578770. &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Cortese M1, Riise T2, Bjørnevik K3, Holmøy T4, Kampman MT5, Magalhaes S6, Pugliatti M7, Wolfson C8, Myhr KM9.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1The KG Jebsen Centre for MS-Research, Department of Clinical Medicine, University of Bergen, Norway/Department of Global Public Health and Primary Care, University of Bergen, Norway/Department of Nutrition, Harvard T.H. Chan School of Public Health, USA &lt;a href="mailto:Marianna.Cortese@igs.uib.no">Marianna.Cortese@igs.uib.no&lt;/a>.&lt;/p></description></item><item><title>Neuromyelitis optica (Devic's Disease is not MS) is also associated with low vitamin D</title><link>/posts/neuromyelitis-optica-devics-disease-is-not-ms-is-also-associated-with-low-vitamin-d.html</link><pubDate>Sat, 25 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/neuromyelitis-optica-devics-disease-is-not-ms-is-also-associated-with-low-vitamin-d.html</guid><description>&lt;h4 id="reduced-serum-vitamin-d-levels-in-neuromyelitis-optica">Reduced serum vitamin D levels in neuromyelitis optica&lt;/h4>
&lt;p>Neurological Sciences, April 2015 &lt;a href="https://doi.org/10.1007/s10072-015-2229-7">https://doi.org/10.1007/s10072-015-2229-7&lt;/a>&lt;/p>
&lt;p>Erdem Tüzün &lt;a href="mailto:drerdem@yahoo.com">drerdem@yahoo.com&lt;/a> (1), Özlem Küçükhüseyin (2), Murat Kürtüncü (3)&lt;/p>
&lt;p>Recai Türkoğlu (4), İlhan Yaylım (2)&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Neuroscience, Institute for Experimental Medical Research (DETAE), Istanbul University, Vakif Gureba Street, Capa, 34390, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Molecular Medicine, Institute for Experimental Medical Research (DETAE), Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey&lt;/p></description></item><item><title>Could Canada cause multiple sclerosis (MS increased 2X in 5 years)</title><link>/posts/could-canada-cause-multiple-sclerosis-ms-increased-2x-in-5-years.html</link><pubDate>Tue, 21 Apr 2015 00:00:00 +0000</pubDate><guid>/posts/could-canada-cause-multiple-sclerosis-ms-increased-2x-in-5-years.html</guid><description>&lt;h3 id="could-canada-cause-multiple-sclerosishttpwwwmacleanscasocietyhealthcould-canada-cause-multiple-sclerosis-macleans">&lt;a href="http://www.macleans.ca/society/health/could-canada-cause-multiple-sclerosis/">Could Canada cause multiple sclerosis?&lt;/a> Macleans&lt;/h3>
&lt;p> &lt;/p>
&lt;p>&lt;strong>“Welcome to MS nation,” one billboard reads. “World leader in hockey, maple syrup and multiple sclerosis,”&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&amp;ldquo;Canadians as young as 2 years old are developing MS&amp;rdquo;&lt;/strong>&lt;/p>
&lt;p>Vitamin D is barely mentioned, but just two clicks deep finds finds a &lt;a href="https://www.youtube.com/watch?t=27&amp;amp;v=CFdp32AEnhI">90 second YouTube video on MS and Vitamin D&lt;/a>&lt;/p>
&lt;h3 id="snips-from-comments-on-the-article-are-interesting">Snips from comments on the article are interesting&lt;/h3>
&lt;ul>
&lt;li>
&lt;ol>
&lt;li>Last year they spent 40% of their $ 50 million on fundraising.&lt;/li>
&lt;/ol>
&lt;/li>
&lt;li>
&lt;ol start="2">
&lt;li>Last year they spent another 40% on salaries.&lt;/li>
&lt;/ol>
&lt;/li>
&lt;li>
&lt;ol start="3">
&lt;li>There are people working at the MS Society of Canada who make more than our Prime Minister…..&lt;/li>
&lt;/ol>
&lt;/li>
&lt;li>
&lt;p>Their contribution to RESEARCH in their last fiscal period DECREASED by $1 million dollars, whilst their salaries INCREASED by pretty much the same amount.&lt;/p></description></item><item><title>People with health problems lacking noon sun (severe Multiple Sclerosis, etc.) have even lower levels of vitamin D</title><link>/posts/people-with-health-problems-lacking-noon-sun-severe-multiple-sclerosis-etc-have--ls-of-vitamin-d.html</link><pubDate>Sun, 15 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/people-with-health-problems-lacking-noon-sun-severe-multiple-sclerosis-etc-have--ls-of-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-is-associated-with-degree-of-disability-in-patients-with-fully-ambulatory-relapsing-remitting-multiple-sclerosis">Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.&lt;/h4>
&lt;p>Eur J Neurol. 2015 Mar;22(3):564-9. &lt;a href="https://doi.org/10.1111/ene.12617.">doi: 10.1111/ene.12617.&lt;/a> Epub 2014 Dec 20.&lt;/p>
&lt;p>Thouvenot E1, Orsini M, Daures JP, Camu W.&lt;/p>
&lt;p>BACKGROUND AND PURPOSE:&lt;/p>
&lt;p>Vitamin D deficiency is a recognized risk factor for multiple sclerosis (MS) and is associated with increased disease activity. It has also been proposed that the lower the vitamin D levels are, the higher is the handicap.&lt;/p></description></item><item><title>Hypothesis – Multiple Sclerosis risk increases with low UV, viral infections, and antibiotics in childhood</title><link>/posts/hypothesis-multiple-sclerosis-risk-increases-with-low-uv-viral-infections-and-an-cs-in-childhood.html</link><pubDate>Sat, 07 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/hypothesis-multiple-sclerosis-risk-increases-with-low-uv-viral-infections-and-an-cs-in-childhood.html</guid><description>&lt;h3 id="environmental-factors-in-multiple-sclerosis">Environmental factors in multiple sclerosis.&lt;/h3>
&lt;p>Presse Med. 2015 Mar 2. pii: S0755-4982(15)00064-0. &lt;a href="https://doi.org/10.1016/j.lpm.2015.01.001.">doi: 10.1016/j.lpm.2015.01.001.&lt;/a> &lt;span>[Epub ahead of print]&lt;/span>&lt;/p>
&lt;p>Pantazou V1, Schluep M1, Du Pasquier R2.&lt;/p>
&lt;p>1CHUV, University Hospital of Lausanne, Department of Clinical Neurosciences, Service of Neurology, 1011 Lausanne, Switzerland.&lt;/p>
&lt;p>2CHUV, University Hospital of Lausanne, Department of Clinical Neurosciences, Service of Neurology, 1011 Lausanne, Switzerland; CHUV, University Hospital of Lausanne, Centre of Research in Clinical Neurosciences, Laboratory of Neuroimmunology, 1011 Lausanne, Switzerland. Electronic address: &lt;a href="mailto:renaud.du-pasquier@chuv.ch">renaud.du-pasquier@chuv.ch&lt;/a>.&lt;/p></description></item><item><title>Multiple Sclerosis is associated with about 1.5 X more Vitamin D Binding Protein</title><link>/posts/multiple-sclerosis-is-associated-with-about-15-x-more-vitamin-d-binding-protein.html</link><pubDate>Sun, 18 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-associated-with-about-15-x-more-vitamin-d-binding-protein.html</guid><description/></item><item><title>Multiple sclerosis patients have 15 ng lower levels of vitamin D – meta-analysis</title><link>/posts/multiple-sclerosis-patients-have-15-ng-lower-levels-of-vitamin-d-meta-analysis.html</link><pubDate>Tue, 16 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-have-15-ng-lower-levels-of-vitamin-d-meta-analysis.html</guid><description>&lt;h3 id="vitamin-d-status-and-the-risk-of-multiple-sclerosis-a-systematic-review-and-meta-analysis">Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis.&lt;/h3>
&lt;p>Neurosci Lett. 2014 Jun 6;570:108-13. &lt;a href="https://doi.org/10.1016/j.neulet.2014.04.021.">doi: 10.1016/j.neulet.2014.04.021.&lt;/a> Epub 2014 Apr 24.&lt;/p>
&lt;p>Duan S1, Lv Z2, Fan X1, Wang L1, Han F1, Wang H1, Bi S3.&lt;/p>
&lt;p>1Department of Neurology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.&lt;/p>
&lt;p>2Department of Rehabilitation, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.&lt;/p>
&lt;p>3Department of Neurology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China. Electronic address: &lt;a href="mailto:bisheng13224510036@163.com">bisheng13224510036@163.com&lt;/a>.&lt;/p></description></item><item><title>Brazillian petition to permit high vitamin D doses for autoimune diseases</title><link>/posts/brazillian-petition-to-permit-high-vitamin-d-doses-for-autoimune-diseases.html</link><pubDate>Sun, 12 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/brazillian-petition-to-permit-high-vitamin-d-doses-for-autoimune-diseases.html</guid><description>&lt;h4 id="brazilian-association-of-neurology-abn-manifesto-of-patients-with-diseases-autoimmune-making-of-high-doses-of-vitamin-d-usehttpwwwcitizengoorgensignit10291view">&lt;a href="http://www.citizengo.org/en/signit/10291/view">Brazilian Association of Neurology (ABN): MANIFESTO OF PATIENTS WITH DISEASES autoimmune MAKING OF HIGH DOSES OF VITAMIN D USE&lt;/a>&lt;/h4>
&lt;p>5,821 petitions as of Oct 12, 2014&lt;/p>
&lt;p>Many are patients of Dr. Cicero Galli Coimbra,&lt;/p>
&lt;p>who has has excellent success with decreasing autoimmune diseases such as&lt;/p>
&lt;p>Multiple Sclerosis and Psorasis&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview MS and vitamin D">Overview MS and vitamin D&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis is connected to Vitamin D by gene to gene interactions</title><link>/posts/multiple-sclerosis-is-connected-to-vitamin-d-by-gene-to-gene-interactions.html</link><pubDate>Tue, 07 Oct 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-is-connected-to-vitamin-d-by-gene-to-gene-interactions.html</guid><description>&lt;h3 id="molecular-mechanism-underlying-the-impact-of-vitamin-d-on-disease-activity-of-ms">Molecular mechanism underlying the impact of vitamin D on disease activity of MS.&lt;/h3>
&lt;p>Ann Clin Transl Neurol. 2014 Aug;1(8):605-17. &lt;a href="https://doi.org/10.1002/acn3.91.">doi: 10.1002/acn3.91.&lt;/a> Epub 2014 Aug 22.&lt;/p>
&lt;p>Munger KL1, Köchert K2, Simon KC1, Kappos L3, Polman CH4, Freedman MS5, Hartung HP6, Miller DH7, Montalbán X8, Edan G9, Barkhof F4, Pleimes D2, Sandbrink R10, Ascherio A1, Pohl C11.&lt;/p>
&lt;p>Author information&lt;/p>
&lt;p>1Harvard School of Public Health Boston, Massachusetts.&lt;/p>
&lt;p>2Bayer HealthCare Berlin, Germany.&lt;/p>
&lt;p>3University Hospital Basel Basel, Switzerland.&lt;/p></description></item><item><title>Multiple Sclerosis, gene expression, and vitamin D: Venn diagrams</title><link>/posts/multiple-sclerosis-gene-expression-and-vitamin-d-venn-diagrams.html</link><pubDate>Tue, 26 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-gene-expression-and-vitamin-d-venn-diagrams.html</guid><description>&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mechanism-ms.jpg" alt="image">
&lt;h3 id="molecular-mechanism-underlying-the-impact-of-vitamin-d-on-disease-activity-of-ms">Molecular mechanism underlying the impact of vitamin D on disease activity of MS&lt;/h3>
&lt;p>Annals of Clinical and Translational Neurology, Article first published online: 22 AUG 2014&lt;/p>
&lt;p>Kassandra L. Munger 1,†,*, Karl Köchert 2,†, Kelly C. Simon 1, Ludwig Kappos 3, Chris H. Polman 4, Mark S. Freedman 5, Hans P. Hartung 6, David H. Miller 7, Xavier Montalbán 8, Gilles Edan9, Frederik Barkhof4, Dirk Pleimes2, Rupert Sandbrink2,6, Alberto Ascherio1 and Christoph Pohl2,10&lt;/p></description></item><item><title>What does it mean to CURE, not just treat a disease like Multiple Sclerosis</title><link>/posts/what-does-it-mean-to-cure-not-just-treat-a-disease-like-multiple-sclerosis.html</link><pubDate>Sun, 24 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/what-does-it-mean-to-cure-not-just-treat-a-disease-like-multiple-sclerosis.html</guid><description>&lt;h3 id="why-havent-we-cured-ms-yethttpmultiple-sclerosis-researchblogspotcom201406why-havent-we-cured-ms-yethtml-dr-gavin-giovannoni">&lt;a href="http://multiple-sclerosis-research.blogspot.com/2014/06/why-havent-we-cured-ms-yet.html">Why haven&amp;rsquo;t we cured MS yet?&lt;/a> Dr. Gavin Giovannoni&lt;/h3>
&lt;p>Multiple Sclerosis Research June 2014&lt;/p>
&lt;p>Barts and the London School of Medicine and Dentistry&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;h3 id="a-few-of-the-slides">A few of the slides&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cure-ms-1.jpg" alt="image" width="400">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cure-ms-2.jpg" alt="image" width="400">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cure-ms-3.jpg" alt="image" width="400">
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-ms-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview MS and vitamin D">Overview MS and vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/autoimmune-disorder-patients-in-brazil-helped-by-vitamin-d-video-and-facebook">Autoimmune disorder patients in Brazil helped by vitamin D – video and Facebook – Nov 2012&lt;/a> MS CURED!&lt;/p></description></item><item><title>Multiple Sclerosis and the Vitamin D Receptor – meta-analysis</title><link>/posts/multiple-sclerosis-and-the-vitamin-d-receptor-meta-analysis.html</link><pubDate>Sat, 12 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-the-vitamin-d-receptor-meta-analysis.html</guid><description/></item><item><title>Swallowing problems (dysphagia): in Multiple Sclerosis and Parkinson’s Disease (perhaps low vitamin D)</title><link>/posts/swallowing-problems-dysphagia-in-multiple-sclerosis-and-parkinsons-disease-perhaps-low-vitamin-d.html</link><pubDate>Tue, 01 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/swallowing-problems-dysphagia-in-multiple-sclerosis-and-parkinsons-disease-perhaps-low-vitamin-d.html</guid><description>&lt;ol>
&lt;li>July 2014: Noticed &lt;a href="http://www.slideshare.net/gavingiovannoni/dysphagia-survey-results?qid=fe376289-23e5-4072-a032-eb3680b23786&amp;amp;v=qf1&amp;amp;b=&amp;amp;from_search=4">survey on dysphagia and MS&lt;/a> by a researcher I am following concerning MS and Vitamin D&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>Posting is attached at bottom of this page&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;p>Had to look up the definition of dysphagia&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=dysphagia+%22multiple+sclerosis%22">Searched PubMed for dysphagia &amp;ldquo;multiple sclerosis&amp;rdquo;&lt;/a> 101 items&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Dysphagia+%22Parkinson%27s+disease%22">Searched PubMed for Dysphagia &amp;ldquo;Parkinson&amp;rsquo;s disease&amp;rdquo;&lt;/a> 336 items as of July 2014&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Increasing report of dysphagia and MS (which might be indicative of decreasing levels of vitamin D)&lt;/p></description></item><item><title>Inflammatory diseases: review of vitamin D, with many tables</title><link>/posts/inflammatory-diseases-review-of-vitamin-d-with-many-tables.html</link><pubDate>Fri, 30 May 2014 00:00:00 +0000</pubDate><guid>/posts/inflammatory-diseases-review-of-vitamin-d-with-many-tables.html</guid><description>&lt;h3 id="introduction">Introduction&lt;/h3>
&lt;p>Vitamin D insufficiency or deficiency has increased in the general population and become an important public health issue.1 Vitamin D is mainly known for its favorable effects in calcium and bone metabolism. However, increasing numbers of studies have established that vitamin D insufficiency contributes to a number of diseases, suggesting a range of physiological functions of vitamin D.M Several clinical studies have confirmed that vitamin D plays a crucial role in modulating innate immune responses toward various pathogens.5 Moreover, recent studies indicate that vitamin D can regulate the adaptive immune response in various inflammatory and autoimmune diseases.6,7 These results suggest the beneficial effects of vitamin D supplementation in decreasing the risk and adverse outcomes of inflammatory diseases, although the precise effect remains to be elucidated in large clinical trials.&lt;/p></description></item><item><title>Epigenetics of Multiple Sclerosis</title><link>/posts/epigenetics-of-multiple-sclerosis.html</link><pubDate>Sat, 24 May 2014 00:00:00 +0000</pubDate><guid>/posts/epigenetics-of-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#epigenetics-of-multiple-sclerosis-an-updated-review---2014">Epigenetics of Multiple Sclerosis: An Updated Review - 2014&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="epigenetics-of-multiple-sclerosis-an-updated-review---2014">Epigenetics of Multiple Sclerosis: An Updated Review - 2014&lt;/h4>
&lt;p>NeuroMolecular Medicine March 2014&lt;/p>
&lt;p>Cem İsmail Küçükali, Murat Kürtüncü, Arzu Çoban, Merve Çebi, Erdem Tüzün&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Neuroscience, Institute for Experimental Medicine (DETAE), Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>&lt;a href="mailto:drerdem@yahoo.com">drerdem@yahoo.com&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease characterized with autoimmune response against myelin proteins and progressive axonal loss. The heterogeneity of the clinical course and low concordance rates in monozygotic twins have indicated the involvement of complex heritable and environmental factors in MS pathogenesis. MS is more often transmitted to the next generation by mothers than fathers suggesting an epigenetic influence. One of the possible reasons of this parent-of-origin effect might be the human leukocyte antigen-DRB1*15 allele, which is the major risk factor for MS and regulated by epigenetic mechanisms such as DNA methylation and histone deacetylation. Moreover, major environmental risk factors for MS, vitamin D deficiency, smoking and Ebstein–Barr virus are all known to exert epigenetic changes.&lt;/p></description></item><item><title>Optic neuritis progession into Multiple Sclerosis reduced 68 percent by 50,000 IU of vitamin D weekly</title><link>/posts/optic-neuritis-progession-into-multiple-sclerosis-reduced-68-percent-by-50000-iu-of-vitamin-d-weekly.html</link><pubDate>Thu, 08 May 2014 00:00:00 +0000</pubDate><guid>/posts/optic-neuritis-progession-into-multiple-sclerosis-reduced-68-percent-by-50000-iu-of-vitamin-d-weekly.html</guid><description>&lt;p>&lt;strong>Update Oct 2017: &lt;a href="https://clinicaltrials.gov/ct2/show/NCT03302585?sfpd_d=14">Clinical trial &lt;/a> being started for Optic Neuritis and Vitamin D: 50,000 IU/d of oral vitamin D3 x 5 days followed by 10,000 IU/d of oral vitamin D3 x 85 days Results are due 2023&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#optic-neuritis-progession-into-multiple-sclerosis-reduced-68--by-50000-iu-of-vitamin-d-weekly--2013">Optic neuritis progession into Multiple Sclerosis reduced 68 % by 50,000 IU of vitamin D weekly- 2013&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#all-optic-neuritis-subjects-had-low-vitamn-d-levels---oct-2022">All Optic Neuritis subjects had low vitamn D levels - Oct 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#a-prospective-cohort-study-of-vitamin-d-in-optic-neuritis-recovery---2017">A prospective cohort study of vitamin D in optic neuritis recovery - 2017&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="optic-neuritis-progession-into-multiple-sclerosis-reduced-68--by-50000-iu-of-vitamin-d-weekly--2013">Optic neuritis progession into Multiple Sclerosis reduced 68 % by 50,000 IU of vitamin D weekly- 2013&lt;/h4>
&lt;p>&lt;strong>Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial&lt;/strong>&lt;/p></description></item><item><title>How UVB reduces autoimmune diseases such as Multiple Sclerosis</title><link>/posts/how-uvb-reduces-autoimmune-diseases-such-as-multiple-sclerosis.html</link><pubDate>Tue, 29 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/how-uvb-reduces-autoimmune-diseases-such-as-multiple-sclerosis.html</guid><description>&lt;h4 id="uvb-light-attenuates-the-systemic-immune-response-in-cns-autoimmunity">UVB light attenuates the systemic immune response in CNS autoimmunity&lt;/h4>
&lt;p>Johanna Breuer1,†, Nicholas Schwab PhD1,†, Tilman Schneider-Hohendorf PhD1, Martin Marziniak MD1,2, Hema Mohan PhD1, Urvashi Bhatia1, Catharina C. Groß PhD1, Björn E. Clausen PhD3, Carsten Weishaupt MD4, Thomas A. Luger MD4,5,6, Sven G. Meuth MD, PhD1,5,6, Karin Loser PhD4,5,6,* andHeinz Wiendl MD1,5,6,*&lt;/p>
&lt;p>Annals of Neurology, DOI: 10.1002/ana.24165&lt;/p>
&lt;p>Objective: Environmental conditions (e.g. latitude) play a critical role in the susceptibility and severity of many autoimmune disorders, including Multiple Sclerosis (MS). Here, we investigated the mechanisms underlying the beneficial effects of immune regulatory processes induced in the skin by moderate ultraviolet B (UVB) radiation on central nervous system (CNS) autoimmunity.&lt;/p></description></item><item><title>Multiple Sclerosis has strong associations with Vitamin D – London</title><link>/posts/multiple-sclerosis-has-strong-associations-with-vitamin-d-london.html</link><pubDate>Mon, 28 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-has-strong-associations-with-vitamin-d-london.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#span-stylecolorf00the-study-using-40000-iu-showed-a-huge-decrease-in-msspan">&lt;span style="color:#F00;">The study using 40,000 IU showed a huge decrease in MS&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00reduced-fracture-riskspan">&lt;span style="color:#F00;">Reduced fracture risk&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00fewer-ms-relapses-with-higher-vitamin-dspan">&lt;span style="color:#F00;">Fewer MS relapses with higher vitamin D&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00ms-vitamin-d-and-genes-25xspan">&lt;span style="color:#F00;">MS, Vitamin D, and Genes 2.5X&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00military-found-that-those-with--40ng-of-vitamin-d-were-half-as-likely-to-get-msspan">&lt;span style="color:#F00;">Military found that those with &amp;gt; 40ng of vitamin D were half as likely to get MS&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00less-occurance-of-ms-for-those-who-actually-supplemented-with-vitamin-dspan">&lt;span style="color:#F00;">Less occurance of MS for those who actually supplemented with Vitamin D&lt;/span>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00less-ms-if-migrate-to-a-sunner-climatespan">&lt;span style="color:#F00;">Less MS if migrate to a sunner climate&lt;/span>&lt;/a>&lt;/li>
 &lt;/ul>

 &lt;ul>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h1 id="vitamin-d-and-human-healthhttpmultiple-sclerosis-researchblogspotcom201404vitamin-d-and-human-healthhtml">&lt;a href="http://multiple-sclerosis-research.blogspot.com/2014/04/vitamin-d-and-human-health.html">Vitamin D and human health&lt;/a>&lt;/h1>
&lt;p>Posted by Gavin Giovannoni &lt;a href="mailto:giovannoni.pa@gmail.com">giovannoni.pa@gmail.com&lt;/a> April 28, 2014&lt;/p></description></item><item><title>Video by Dr. Coimbra – 95 percent of auto-immune cured with vitamin D in high doses</title><link>/posts/video-by-dr-coimbra-95-percent-of-auto-immune-cured-with-vitamin-d-in-high-doses.html</link><pubDate>Sat, 19 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/video-by-dr-coimbra-95-percent-of-auto-immune-cured-with-vitamin-d-in-high-doses.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#transcript-in-english-follows">Transcript in English follows&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;p>&lt;strong>Transcript, in original Italian, is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;h4 id="transcript-in-english-follows">Transcript in English follows&lt;/h4>
&lt;p>&lt;strong>auto-translated so there are various errors&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Text bolded by VitaminDWiki&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>0:12 The protocol was created by the following question:&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:16 at a given moment of my professional life,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:20 I felt very strongly the need to try to help change this idea&lt;/p>
&lt;/li>
&lt;li>
&lt;p>0:29 that neurology is a medical specialty made from brilliant diagnostic&lt;/p></description></item><item><title>Multiple Sclerosis patients who increased their vitamin D levels by 20 ng had better outcomes</title><link>/posts/multiple-sclerosis-patients-who-increased-their-vitamin-d-levels-by-20-ng-had-better-outcomes.html</link><pubDate>Sun, 16 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-patients-who-increased-their-vitamin-d-levels-by-20-ng-had-better-outcomes.html</guid><description>&lt;h2 id="vitamin-d-as-an-early-predictor-of-multiple-sclerosis-activity-and-progression">Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression&lt;/h2>
&lt;p>JAMA Neurol. 2014;71(3):306-314. doi:10.1001/jamaneurol.2013.5993. Text Alberto Ascherio, MD, DrPH1; Kassandra L. Munger, ScD1; Rick White, MSc2; Karl Köchert, PhD3; Kelly Claire Simon, ScD1; Chris H. Polman, MD4; Mark S. Freedman, MD5; Hans-Peter Hartung, MD6; David H. Miller, MD7; Xavier Montalbán, MD8; Gilles Edan, MD9; Frederik Barkhof, MD4; Dirk Pleimes, MD10; Ernst-Wilhelm Radü, MD11; Rupert Sandbrink, MD3,6; Ludwig Kappos, MD11; Christoph Pohl, MD3,12&lt;/p></description></item><item><title>MS and vitamin D consensus from Brazil - 40-100 ng, not monotherapy</title><link>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</link><pubDate>Wed, 12 Mar 2014 00:00:00 +0000</pubDate><guid>/posts/ms-and-vitamin-d-consensus-from-brazil-40-100-ng-not-monotherapy.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#supplementation-and-therapeutic-use-of-vitamin-d-in-patients-with-multiple-sclerosis">Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-ms-and-eae">VITAMIN D, MS, AND EAE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#randomized-and-controlled-clinical-trials-with-vitamin-d-in-the-treatment-of-ms">RANDOMIZED AND CONTROLLED CLINICAL TRIALS WITH VITAMIN D IN THE TREATMENT OF MS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-other-issues">VITAMIN D AND OTHER ISSUES&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#safety-profile">SAFETY PROFILE&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d--side-effects">VITAMIN D – SIDE EFFECTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#final-considerations">FINAL CONSIDERATIONS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#acknowledgements">ACKNOWLEDGEMENTS&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="dr-cicero-galli-coimbra-brazil-is-not-mentioned-as-an-author-contributor-nor-as-a-reference">Dr. Cicero Galli Coimbra (Brazil) is not mentioned as an author, contributor, nor as a reference&lt;/h3>
&lt;p>&lt;strong>Suspect it is because Dr. Coimbra:&lt;/strong>&lt;/p></description></item><item><title>Central Nervous System helped by Vitamin D – Review – 2013</title><link>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</link><pubDate>Sat, 08 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/central-nervous-system-helped-by-vitamin-d-review-2013.html</guid><description>&lt;h2 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h2>
&lt;p>Pharmacological Reports 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw,&lt;/p>
&lt;p>Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>Multiple Sclerosis progressed more slowly if have 20 ng more vitamin D</title><link>/posts/multiple-sclerosis-progressed-more-slowly-if-have-20-ng-more-vitamin-d.html</link><pubDate>Wed, 22 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-progressed-more-slowly-if-have-20-ng-more-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-as-an-early-predictor-of-multiple-sclerosis-activity-and-progression">Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comments-by-doctors-on-this-study">Comments by Doctors on this study&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="vitamin-d-as-an-early-predictor-of-multiple-sclerosis-activity-and-progression">Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression&lt;/h3>
&lt;p>JAMA Neurol. 2014 Jan 20. &lt;a href="https://doi.org/10.1001/jamaneurol.2013.5993.">doi: 10.1001/jamaneurol.2013.5993.&lt;/a>&lt;/p>
&lt;p>Ascherio A1, Munger KL1, White R2, Köchert K3, Simon KC1, Polman CH4, Freedman MS5, Hartung HP6, Miller DH7, Montalbán X8, Edan G9, Barkhof F4, Pleimes D10, Radü EW11, Sandbrink R12, Kappos L11, Pohl C13.&lt;/p></description></item><item><title>Fewer white spots in MRI brain scans if had more vitamin D</title><link>/posts/fewer-white-spots-in-mri-brain-scans-if-had-more-vitamin-d.html</link><pubDate>Fri, 17 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/fewer-white-spots-in-mri-brain-scans-if-had-more-vitamin-d.html</guid><description>&lt;h4 id="association-of-white-matter-hyperintensities-with-low-serum-25-hydroxyvitamin-d-levels">Association of White Matter Hyperintensities with Low Serum 25-Hydroxyvitamin D Levels&lt;/h4>
&lt;p>American Journal of Neuroradiology&lt;/p>
&lt;p>J.M. Prager, &lt;a href="mailto:jprager@northshore.org">jprager@northshore.org&lt;/a>, C. Thomas, W.J. Ankenbrandt, J.R. Meyer, Y. Gao, A. Ragin, S. Sidharthan, R. Hutten and Y.G. Wu&lt;/p>
&lt;p>From the Department of Radiology (J.M.P., W.J.A., J.R.M., R.H., Y.G.W.), NorthShore University Health System, Evanston, Illinois; Department of Endocrinology (C.T.), University of Chicago, Chicago, Illinois; Departments of Statistics (Y.G.) and Radiology (A.R.), Northwestern University, Evanston, Illinois; and Department of Radiology (S.S.), Monmouth Medical Center, Long Branch, New Jersey.&lt;/p></description></item><item><title>Hypothesis- birth rate variation with season may trump MS variation with vitamin D</title><link>/posts/hypothesis-birth-rate-variation-with-season-may-trump-ms-variation-with-vitamin-d.html</link><pubDate>Wed, 15 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/hypothesis-birth-rate-variation-with-season-may-trump-ms-variation-with-vitamin-d.html</guid><description>&lt;h3 id="confounding-in-association-studies-month-of-birth-and-multiple-sclerosis">Confounding in association studies: month of birth and multiple sclerosis&lt;/h3>
&lt;p>J Neurol, DOI 10.1007/s00415-014-7241-y&lt;/p>
&lt;p>Barnaby Fiddes, • James Wason, • Stephen Sawcer&lt;/p>
&lt;p>Received: 11 December 2013/Accepted: 2 January 2014&lt;/p>
&lt;p>Association studies form the backbone of biomedical research, with almost every effort in the field ultimately boiling down to a comparison between groups, coupled with some form of statistical test intended to determine whether or not any observed difference is more or less than would be expected by chance. Unfortunately, although the paradigm is powerful and frequently effective, it is often forgotten that false positive association can easily arise if there is any bias or systematic difference in the way in which study subjects are selected into the considered groups. To protect against such confounding, researchers generally try to match cases and controls for extraneous variables thought to correlate with the exposures of interest. However, if seemingly homogenously distributed exposures are actually more heterogeneous than appreciated, then matching may be inadequate and false positive results can still arise. In this review, we will illustrate these fundamental issues by considering the previously proposed relationship between month of birth and multiple sclerosis. This much discussed but false positive association serves as a reminder of just how heterogeneous even easily measured environmental risk factors can be, and how easily case&lt;/p></description></item><item><title>Vitamin D at CureTogether: Fibromyalgia, MS, Psoriasis, etc</title><link>/posts/vitamin-d-at-curetogether-fibromyalgia-ms-psoriasis-etc.html</link><pubDate>Wed, 25 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-at-curetogether-fibromyalgia-ms-psoriasis-etc.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#curetogetherhttpcuretogethercomconditions-crowd-sources-information-on-a-wide-variety-of-health-concerns">&lt;a href="http://curetogether.com/conditions">CureTogether&lt;/a> crowd-sources information on a wide variety of health concerns&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#all-fibromyalgia-cures">All Fibromyalgia Cures&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#fibromyalgia---just-vitamin-d-is-labledhttpcuretogethercomfibromyalgiaigtreatment-effectiveness-vs-popularity">&lt;a href="http://curetogether.com/fibromyalgia/ig/treatment-effectiveness-vs-popularity">Fibromyalgia - just vitamin D is labled&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#psoriasishttpcuretogethercompsoriasisigtreatment-effectiveness-vs-popularity-and-sunlight">&lt;a href="http://curetogether.com/psoriasis/ig/treatment-effectiveness-vs-popularity">Psoriasis&lt;/a> and sunlight&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-sclerosishttpcuretogethercommultiple-sclerosisigtreatment-effectiveness-vs-popularity">&lt;a href="http://curetogether.com/multiple-sclerosis/ig/treatment-effectiveness-vs-popularity">Multiple Sclerosis&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#crohns-disease">Crohn&amp;rsquo;s Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#opinions-of-vitamin-d-deficiency-treatmentshttpcuretogethercomvitamin-d-deficiencytreatments">&lt;a href="http://curetogether.com/vitamin-d-deficiency/treatments/">Opinions of Vitamin D deficiency treatments&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#symptoms-of-vitamin-d-deficiencyhttpcuretogethercomvitamin-d-deficiencysymptoms-sorted-by-popularity">&lt;a href="http://curetogether.com/vitamin-d-deficiency/symptoms/">Symptoms of Vitamin D Deficiency&lt;/a> Sorted by popularity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#symptom-severityhttpcuretogethercomvitamin-d-deficiencysymptoms">&lt;a href="http://curetogether.com/vitamin-d-deficiency/symptoms/">Symptom Severity&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#curetogether-categories-as-of-dec-2013">CureTogether categories as of Dec 2013&lt;/a>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#musculoskeletal">Musculoskeletal&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#digestive-system">Digestive System&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#skin-and-hair">Skin and Hair&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cardiovascular-and-blood">Cardiovascular and Blood&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#womens-health">Women&amp;rsquo;s Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#respiratory">Respiratory&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#infectious">Infectious&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#injuries">Injuries&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#genetic-disorders">Genetic Disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mental-health">Mental Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#neurological">Neurological&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#eyes-and-ears">Eyes and Ears&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#endocrine-and-metabolic">Endocrine and Metabolic&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mens-health">Men&amp;rsquo;s Health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#urological">Urological&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#sexual">Sexual&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#patientslikeme-is-somewhat-similarhttpswwwpatientslikemecomtreatmentsshow322-vitamin-d-side-effects-and-efficacybrandfoverview">&lt;a href="https://www.patientslikeme.com/treatments/show/322-vitamin-d-side-effects-and-efficacy?brand=f#overview">PatientsLikeMe is somewhat similar&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="curetogetherhttpcuretogethercomconditions-crowd-sources-information-on-a-wide-variety-of-health-concerns">&lt;a href="http://curetogether.com/conditions">CureTogether&lt;/a> crowd-sources information on a wide variety of health concerns&lt;/h2>
&lt;p>&lt;strong>Has been a part of 23andMe since July 2012&lt;/strong> (DNA prediction of health problems for $99 as of Dce 2013)&lt;/p></description></item><item><title>Review of clinical trials for Multiple Sclerosis with Vitamin D intervention – 2013</title><link>/posts/review-of-clinical-trials-for-multiple-sclerosis-with-vitamin-d-intervention-2013.html</link><pubDate>Thu, 28 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/review-of-clinical-trials-for-multiple-sclerosis-with-vitamin-d-intervention-2013.html</guid><description>&lt;h3 id="can-we-prevent-or-treat-multiple-sclerosis-by-individualised-vitamin-d-supply">Can we prevent or treat multiple sclerosis by individualised vitamin D supply?&lt;/h3>
&lt;p>EPMA Journal 2013, 4:4 doi:10.1186/1878-5085-4-4&lt;/p>
&lt;p>Jan Dörr 12 &lt;a href="mailto:jan-markus.doerr@charite.de">jan-markus.doerr@charite.de&lt;/a>, Andrea Döring 123 and Friedemann Paul 12&lt;/p>
&lt;p>1 NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany&lt;/p>
&lt;p>2 Clinical and Experimental Research Center for Multiple Sclerosis, Charité - Universitätsmedizin Berlin, Berlin, Germany&lt;/p>
&lt;p>3 Current address: Department of Neurology, DIAKO, Flensburg, Germany&lt;/p>
&lt;p>Apart from its principal role in bone metabolism and calcium homeostasis, vitamin D has been attributed additional effects including an immunomodulatory, anti-inflammatory, and possibly even neuroprotective capacity which implicates a possible role of vitamin D in autoimmune diseases like multiple sclerosis (MS). Indeed, several lines of evidence including epidemiologic, preclinical, and clinical data suggest that reduced vitamin D levels and/or dysregulation of vitamin D homeostasis is a risk factor for the development of multiple sclerosis on the one hand, and that vitamin D serum levels are inversely associated with disease activity and progression on the other hand. However, these data are not undisputable, and many questions regarding the preventive and therapeutic capacity of vitamin D in multiple sclerosis remain to be answered. In particular, available clinical data derived from interventional trials using vitamin D supplementation as a therapeutic approach in MS are inconclusive and partly contradictory. In this review, we summarise and critically evaluate the existing data on the possible link between vitamin D and multiple sclerosis in light of the crucial question whether optimization of vitamin D status may impact the risk and/or the course of multiple sclerosis.&lt;/p></description></item><item><title>Iran Multiple Sclerosis review finds huge increase in women (no mention of clothing)</title><link>/posts/iran-multiple-sclerosis-review-finds-huge-increase-in-women-no-mention-of-clothing.html</link><pubDate>Fri, 08 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/iran-multiple-sclerosis-review-finds-huge-increase-in-women-no-mention-of-clothing.html</guid><description>&lt;h3 id="epidemiology-of-multiple-sclerosis-in-iran-a-systematic-review">Epidemiology of Multiple Sclerosis in Iran: A Systematic Review&lt;/h3>
&lt;p>Etemadifar M.a, b · Sajjadi S.b, c · Nasr Z.b, c · Firoozeei T.S.b · Abtahi S.-H.b, c · Akbari M.d · Fereidan-Esfahani M.b,c,e&lt;/p>
&lt;p>A Department of Neurology, Medical School, b Isfahan Research Committee of Multiple Sclerosis (IRCOMS), c Medical Students&amp;rsquo; Research Committee, d Department of Epidemiology and Statistics, Isfahan University of Medical Science, and e Persia Research Center, Sady Hospital, Isfahan, Iran&lt;/p></description></item><item><title>Incidence of Multiple Sclerosis in Bulgaria increased 2X in 17 years, thinking about vitamin D</title><link>/posts/incidence-of-multiple-sclerosis-in-bulgaria-increased-2x-in-17-years-thinking-about-vitamin-d.html</link><pubDate>Thu, 07 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/incidence-of-multiple-sclerosis-in-bulgaria-increased-2x-in-17-years-thinking-about-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-immunomodulatory-potential-in-multiple-sclerosis">Vitamin D immunomodulatory potential in multiple sclerosis.&lt;/h2>
&lt;p>Folia Med (Plovdiv). 2013 Apr-Jun;55(2):5-9.&lt;/p>
&lt;p>Slavov GS, Trenova AG, Manova MG, Kostadinova II, Vasileva TV, Zahariev ZI.&lt;/p>
&lt;p>Department of Neurology, Medical University, Plovdiv, Bulgaria. &lt;a href="mailto:eorgi.slavov.15130@gmail.com">eorgi.slavov.15130@gmail.com&lt;/a>&lt;/p>
&lt;p>Multiple sclerosis (MS) is an autoimmune disease of unknown etiology whose treatment is of limited efficiency and therefore has a high social burden. As it has been suggested that myelin destruction model, the clinical manifestation and the potential of therapeutic response in MS are correlated, it is quite justifiable that we study various factors (genetic, hormonal, environmental) that take part in the autoimmune process in order to improve the control over the disrupted immune regulation. Results from epidemiological and clinical studies clearly suggest that changes in vitamin D serum concentrations are correlated with the magnitude of the risk of developing MS, the phases of relapse and remittance and with gender differences in vitamin D metabolism. Experimental and clinical studies also have established that 25-hydroxy vitamin D (25(OH)D) and 1,25-dihydroxy vitamin D (1,25(OH)2D) exert an immunomodulatory effect in the central nervous system and peripheral organs of the immune system. The standard reference range of vitamin D concentration in serum is 50-80 nmol/l- -it provides normal calcium metabolism. Issues that are discussed include the vitamin D serum concentration needed to suppress the aberrant immune response in MS patients; a subgroup of MS patients suitable for vitamin D treatment, the vitamin D being applied in optimally effective and safe dosage.&lt;/p></description></item><item><title>Multiple Sclerosis increased 10 percent in 5 years</title><link>/posts/multiple-sclerosis-increased-10-percent-in-5-years.html</link><pubDate>Mon, 28 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-increased-10-percent-in-5-years.html</guid><description/></item><item><title>Acute Multiple Sclerosis relapse associated with low bone mineral density (low vitamin D)</title><link>/posts/acute-multiple-sclerosis-relapse-associated-with-low-bone-mineral-density-low-vitamin-d.html</link><pubDate>Sat, 12 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/acute-multiple-sclerosis-relapse-associated-with-low-bone-mineral-density-low-vitamin-d.html</guid><description>&lt;h3 id="patients-with-an-acute-multiple-sclerosis-relapse-a-high-risk-group-for-osteopenia-and-osteoporosis">PATIENTS WITH AN ACUTE MULTIPLE SCLEROSIS RELAPSE: A HIGH RISK GROUP FOR OSTEOPENIA AND OSTEOPOROSIS&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.194&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Olwen Murphy⇓, Michael S Zandi, Nitzan Lindenberg, Elaine Murphy, Jeremy Chataway&lt;/p>
&lt;p>National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London.&lt;/p>
&lt;p>Objective To evaluate the bone health of a cohort of patients with an acute Multiple Sclerosis (MS) relapse and to develop an algorithm for the management of bone health in this patient group.&lt;/p></description></item><item><title>Update on Treating Multiple Sclerosis with high dose vitamin D</title><link>/posts/update-on-treating-multiple-sclerosis-with-high-dose-vitamin-d.html</link><pubDate>Sun, 29 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/update-on-treating-multiple-sclerosis-with-high-dose-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis prevention by Vitamin D: 10 year, 30 million dollar trial</title><link>/posts/multiple-sclerosis-prevention-by-vitamin-d-10-year-30-million-dollar-trial.html</link><pubDate>Sun, 22 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-prevention-by-vitamin-d-10-year-30-million-dollar-trial.html</guid><description>&lt;p>MS Research Australia&lt;/p>
&lt;p>The trial will be for MS prevention, not treatment - which looks very possible&lt;/p>
&lt;p>1000, 5000 &amp;amp; 10,000 IU of Vitamin D, + placebo&lt;/p>
&lt;p>&lt;a href="http://www.afr.com/p/australia2-0/major_ms_trial_to_throw_light_on_N4dXK1stpqkTETWNqo3JPP">CLICK HERE&lt;/a> for the story of the CEO who got MS, and then added funding to the study&lt;/p></description></item><item><title>Vitamin D may not be the only cause of Multiple Sclerosis in Scotland</title><link>/posts/vitamin-d-may-not-be-the-only-cause-of-multiple-sclerosis-in-scotland.html</link><pubDate>Sun, 18 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-may-not-be-the-only-cause-of-multiple-sclerosis-in-scotland.html</guid><description>&lt;h2 id="vitamin-d-not-the-sole-cause-of-high-ms-rates-in-northern-isles-says-scientisthttpwwwshetlandtimescouk20130818vitamin-d-not-the-sole-cause-of-high-ms-rates-in-northern-isles-says-scientist">&lt;a href="http://www.shetlandtimes.co.uk/2013/08/18/vitamin-d-not-the-sole-cause-of-high-ms-rates-in-northern-isles-says-scientist">Vitamin D not the sole cause of high MS rates in northern isles, says scientist&lt;/a>&lt;/h2>
&lt;p>August 18th, 2013 by Malachy Tallack&lt;/p>
&lt;p>Vitamin D deficiency is unlikely to be “the single explanatory factor” for the very high rates of multiple sclerosis (MS) in Orkney and Shetland, according to the scientist who has led research into the subject.&lt;/p>
&lt;p>Dr Jim Wilson was in Lerwick this week to discuss the initial results of the Northern Isles Vitamin D Study, which tested blood samples from 2,300 people in the islands.&lt;/p></description></item><item><title>Multiple Sclerosis: number needed to treat with vitamin D may be as low as 1.3 – Meta-analysis</title><link>/posts/multiple-sclerosis-number-needed-to-treat-with-vitamin-d-may-be-as-low-as-13-meta-analysis.html</link><pubDate>Wed, 24 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-number-needed-to-treat-with-vitamin-d-may-be-as-low-as-13-meta-analysis.html</guid><description>&lt;h4 id="the-case-for-vitamin-d-supplementation-in-multiple-sclerosis">The case for vitamin D supplementation in multiple sclerosis&lt;/h4>
&lt;p>Multiple Sclerosis and Related Disorders, Volume 2, Issue 4, October 2013, Pages 281–306 &lt;a href="https://doi.org/10.1016/j.msard.2012.12.008">https://doi.org/10.1016/j.msard.2012.12.008&lt;/a>&lt;/p>
&lt;p>Aravind Ganesh a, &lt;a href="mailto:aravindganeshy@yahoo.ca">aravindganeshy@yahoo.ca&lt;/a>; Sabrina Apel b, Luanne Metz c, Scott Patten d,&lt;/p>
&lt;ul>
&lt;li>
&lt;p>a Resident, Clinical Neurosciences, University of Calgary, 1403 29 Street NW Calgary, Alberta, Canada T2N 2T9&lt;/p>
&lt;/li>
&lt;li>
&lt;p>b Undergraduate Medical Education, University of Calgary, 33 Discovery Rise SW Calgary, Alberta, Canada T3H 4N6&lt;/p>
&lt;/li>
&lt;li>
&lt;p>c Clinical Neurosciences, University of Calgary, 1403 29 Street NW Calgary, Alberta, Canada T2N 2T9&lt;/p></description></item><item><title>Melatonin interacts with Vitamin D in Multiple Sclerosis patients</title><link>/posts/melatonin-interacts-with-vitamin-d-in-multiple-sclerosis-patients.html</link><pubDate>Sun, 21 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/melatonin-interacts-with-vitamin-d-in-multiple-sclerosis-patients.html</guid><description>&lt;h4 id="latitude-vitamin-d-melatonin-and-gut-microbiota-act-in-concert-to-initiate-multiple-sclerosis">Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis:&lt;/h4>
&lt;p>A New Mechanistic Pathway - 2018&lt;/p>
&lt;p>&lt;strong>See &lt;a href="/posts/a-multiple-sclerosis-hypothesis-supported-by-eae-data" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: A Multiple Sclerosis hypothesis supported by EAE data – Oct 2018">A Multiple Sclerosis hypothesis supported by EAE data – Oct 2018&lt;/a>&lt;/strong>&lt;/p>
&lt;hr>
&lt;h4 id="disruption-of-melatonin-circadian-rhythm-production-is-related-to-multiple-sclerosis-severity-a-preliminary-study---2015">Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study - 2015&lt;/h4>
&lt;p>&lt;strong>&amp;ldquo;In conclusion, disruption of melatonin circadian rhythm production is frequent among RRMS patients and seemingly related to higher disability and fatigue scores&amp;rdquo;     &lt;a href="https://doi.org/10.1016/j.jns.2015.03.040">doi: 10.1016/j.jns.2015.03.040&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Vitamin D and MS, ALS, Autism, Alzheimer’s and other nervous system diseases – review</title><link>/posts/vitamin-d-and-ms-als-autism-alzheimers-and-other-nervous-system-diseases-review.html</link><pubDate>Sat, 13 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-ms-als-autism-alzheimers-and-other-nervous-system-diseases-review.html</guid><description>&lt;h2 id="review-the-role-of-vitamin-d-in-nervous-system-health-and-disease">Review: The role of vitamin D in nervous system health and disease&lt;/h2>
&lt;p>Neuropathology and Applied Neurobiology. Volume 39, Issue 5, pages 458–484, August 2013&lt;/p>
&lt;p>G. C. DeLuca 1,gabriele.deluca@ndcn.ox.ac.uk&lt;/p>
&lt;p>S. M. Kimball 3,&lt;/p>
&lt;p>J. Kolasinski 1,&lt;/p>
&lt;p>S. V. Ramagopalan 2,&lt;/p>
&lt;p>G. C. Ebers 1&lt;/p>
&lt;p>1 Nuffield Department of Clinical Neurosciences (Clinical Neurology), University of Oxford, Oxford&lt;/p>
&lt;p>2 Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK&lt;/p></description></item><item><title>Full-on Multiple Sclerosis was 3.3X more likely in patients with the lowest vitamin D levels</title><link>/posts/full-on-multiple-sclerosis-was-33x-more-likely-in-patients-with-the-lowest-vitamin-d-levels.html</link><pubDate>Wed, 10 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/full-on-multiple-sclerosis-was-33x-more-likely-in-patients-with-the-lowest-vitamin-d-levels.html</guid><description>&lt;h3 id="vitamin-d-levels-and-risk-of-multiple-sclerosis-in-patients-with-clinically-isolated-syndromes">Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.&lt;/h3>
&lt;p>Mult Scler. 2013 Jul 8.&lt;/p>
&lt;p>Martinelli V, Dalla Costa G, Colombo B, Dalla Libera D, Rubinacci A, Filippi M, Furlan R, Comi G.&lt;/p>
&lt;p>Department of Neurology, San Raffaele Hospital, Milan, Italy.&lt;/p>
&lt;p>BACKGROUND: Growing evidence suggests that vitamin D deficiency may be one of the most important environmental factors for the development of multiple sclerosis (MS).&lt;/p>
&lt;p>OBJECTIVES: The objectives of this paper are to evaluate serum 25-hydroxyvitamin D (25(OH)D) levels in patients with clinically isolated syndromes (CIS) and to examine whether they are related to MS risk.&lt;/p></description></item><item><title>UV decreases Multiple Sclerosis via cis-urocanic acid (and via vitamin D)</title><link>/posts/uv-decreases-multiple-sclerosis-via-cis-urocanic-acid-and-via-vitamin-d.html</link><pubDate>Thu, 27 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/uv-decreases-multiple-sclerosis-via-cis-urocanic-acid-and-via-vitamin-d.html</guid><description>&lt;h2 id="modulation-of-multiple-sclerosis-by-sunlight-exposure-role-of-cis-urocanic-acid">Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid&lt;/h2>
&lt;p>Jorge Correale &lt;a href="mailto:jcorreale@fleni.org.ar">jcorreale@fleni.org.ar&lt;/a> , Mauricio F. Farez&lt;/p>
&lt;p>Received 16 March 2013; published online 24 June 2013.&lt;/p>
&lt;p>The role of cis-urocanic acid (UCA) as a UV-mediated immunomodulator in MS patients was investigated. Plasma levels of cis-UCA were significantly lower in MS patients compared to controls. Stimulation of MBP- and MOG-specific T cells in the presence of cis-UCA, significantly increased IL-10, and inhibited IFN-γ production. PBMCs cultured in the presence of cis-UCA increased CD4+CD25+FoxP3+ regulatory T cell percentages. Dendritic cells cultured in the presence of cis-UCA significantly reduced Ag presentation capacity. Finally, cis-UCA activated the 5-HT2A receptor, inducing the increase in phosphorylated forms of ERK 1/2 and JNK2. Thus, in addition to vitamin D, cis-UCA also appears to be an additional UV-mediated immunomodulator.&lt;/p></description></item><item><title>Increased risk of multiple sclerosis risk in African Americans due to genes</title><link>/posts/increased-risk-of-multiple-sclerosis-risk-in-african-americans-due-to-genes.html</link><pubDate>Thu, 20 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/increased-risk-of-multiple-sclerosis-risk-in-african-americans-due-to-genes.html</guid><description>&lt;h3 id="genetic-risk-variants-in-african-americans-with-multiple-sclerosis">Genetic risk variants in African Americans with multiple sclerosis&lt;/h3>
&lt;p>Neurology 10.1212/WNL.0b013e31829bfe2f&lt;/p>
&lt;p>Noriko Isobe, MD, PhD,&lt;/p>
&lt;p>Pierre-Antoine Gourraud, PhD, MPH,&lt;/p>
&lt;p>Hanne F. Harbo, MD, PhD,&lt;/p>
&lt;p>Stacy J. Caillier, BS,&lt;/p>
&lt;p>Adam Santaniello, BS,&lt;/p>
&lt;p>Pouya Khankhanian, BA,&lt;/p>
&lt;p>Martin Maiers, MS,&lt;/p>
&lt;p>Stephen Spellman, MBS,&lt;/p>
&lt;p>Nezih Cereb, MD,&lt;/p>
&lt;p>SooYoung Yang, PhD,&lt;/p>
&lt;p>Marcelo J. Pando, PhD,&lt;/p>
&lt;p>Laura Piccio, MD, PhD,&lt;/p>
&lt;p>Anne H. Cross, MD,&lt;/p>
&lt;p>Philip L. De Jager, MD, PhD,&lt;/p>
&lt;p>Bruce A.C. Cree, MD, PhD, MCR,&lt;/p></description></item><item><title>MS flu-like symptoms resulting from interferon-beta were reduced with vitamin D</title><link>/posts/ms-flu-like-symptoms-resulting-from-interferon-beta-were-reduced-with-vitamin-d.html</link><pubDate>Sat, 15 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/ms-flu-like-symptoms-resulting-from-interferon-beta-were-reduced-with-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-supplementation-for-patients-with-multiple-sclerosis-treated-with-interferon-beta">Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta:&lt;/h4>
&lt;p>a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties&lt;/p>
&lt;p>BMC Neurology 2013, 13:60 doi:10.1186/1471-2377-13-60; Published: 14 June 2013&lt;/p>
&lt;p>Daniel Golan, Basheer Halhal, Lea Glass-Marmor, Elsebeth Staun-Ram, Orit Rozenberg, Idit Lavi, Sara Dishon, Mira Barak, Sophia Ish-Shalom and Ariel Miller&lt;/p>
&lt;p>Background: Flu-like symptoms (FLS) are common side effects of interferon beta (IFN-beta) treatment in patients with Multiple Sclerosis (PwMS) and are associated with post-injection cytokine surge.&lt;/p></description></item><item><title>98 pcnt of genes that Vitamin D activates to reduce MS are also activated by Interferon</title><link>/posts/98-pcnt-of-genes-that-vitamin-d-activates-to-reduce-ms-are-also-activated-by-interferon.html</link><pubDate>Thu, 06 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/98-pcnt-of-genes-that-vitamin-d-activates-to-reduce-ms-are-also-activated-by-interferon.html</guid><description>&lt;h4 id="25-hydroxyvitamin-d-and-ms-activity-during-therapy-with-interferon-beta-1b">25-Hydroxyvitamin D and MS Activity During Therapy with Interferon Beta-1b&lt;/h4>
&lt;p>&lt;a href="https://cmscactrims.confex.com/cmscactrims/2013/webprogram/Paper1448.html%20">CMSC Conference, May 30, 2013 &lt;/a> Florida&lt;/p>
&lt;p>Alberto Ascherio, MD , Harvard University, Boston, MA&lt;/p>
&lt;p>Kassandra Munger, ScD , Harvard University, Boston, MA&lt;/p>
&lt;p>Claire Simon, ScD , Harvard University, Boston, MA&lt;/p>
&lt;p>Ludwig Kappos, MD , University Hospital, Basel Neurology, Basel, Switzerland, Basel, Switzerland&lt;/p>
&lt;p>Chris H Polman, MD , VU Medical Center, Amsterdam, Netherlands&lt;/p>
&lt;p>Mark Freedman, MD , University of Ottawa, Ottawa, ON, Canada&lt;/p></description></item><item><title>Vitamin D is important for the central nervous system and cognition</title><link>/posts/vitamin-d-is-important-for-the-central-nervous-system-and-cognition.html</link><pubDate>Thu, 06 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-important-for-the-central-nervous-system-and-cognition.html</guid><description>&lt;h3 id="vitamin-d-and-the-central-nervous-system">Vitamin D and the central nervous system&lt;/h3>
&lt;p>Pharmacological Reports, 2013, 65, 271-278 ISSN 1734-1140&lt;/p>
&lt;p>Matgorzata Wrzosek1, Jacek tukaszkiewicz2, Michat Wrzosek3, Andrzej Jakubczyk4, Halina Matsumoto4, Pawet Piatkiewicz3, Maria Radziwoh-Zaleska4, Marcin Wojnar4,5, Grazyna Nowicka1&lt;/p>
&lt;p>department of Pharmacogenomics, department of Biochemistry and Clinical Chemistry,&lt;/p>
&lt;p>department of Internal Medicine and Diabetology, department of Psychiatry, Medical University of Warsaw, Zwirki i Wigury 61, PL 02-091 Warszawa, Poland&lt;/p>
&lt;p>department of Psychiatry, University of Michigan, 4250 Plymouth Rd., Ann Arbor, MI 48109, USA Correspondence: Grazyna Nowicka, e-mail: &lt;a href="mailto:grazyna.nowicka@wum.edu.p">grazyna.nowicka@wum.edu.p&lt;/a>&lt;/p></description></item><item><title>No association between Multiple Sclerosis relapses and being treated with vitamin D–meta-analysis</title><link>/posts/no-association-between-multiple-sclerosis-relapses-and-being-treated-with-vitamin-dmeta-analysis.html</link><pubDate>Thu, 23 May 2013 00:00:00 +0000</pubDate><guid>/posts/no-association-between-multiple-sclerosis-relapses-and-being-treated-with-vitamin-dmeta-analysis.html</guid><description>&lt;p>&lt;strong>This is most likely similar to many other meta-analysis which find no association when averaging the response by people getting no benefit from as little as 400 IU with those getting a lot of benefit from 10,000 IU&lt;/strong>&lt;/p>
&lt;h2 id="the-effect-of-vitamin-d-related-interventions-on-multiple-sclerosis-relapses-a-meta-analysis">The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis&lt;/h2>
&lt;p>Mult Scler May 22, 2013 1352458513489756&lt;/p>
&lt;p>Eleanor James, Ruth Dobson, Jens Kuhle, David Baker, Gavin Giovannoni, Sreeram V Ramagopalan&lt;/p>
&lt;p>Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK&lt;/p></description></item><item><title>Season of birth associated with Pneumonia (10 %) and Multiple Sclerosis (30 %)</title><link>/posts/season-of-birth-associated-with-pneumonia-10-percent-and-multiple-sclerosis-30-percent.html</link><pubDate>Fri, 17 May 2013 00:00:00 +0000</pubDate><guid>/posts/season-of-birth-associated-with-pneumonia-10-percent-and-multiple-sclerosis-30-percent.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#no-effect-of-season-of-birth-on-risk-of-type-1-diabetes-cancer-schizophrenia-and-ischemic-heart-disease-while-some-variations-may-be-seen-for-pneumonia-and-multiple-sclerosis">No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="no-effect-of-season-of-birth-on-risk-of-type-1-diabetes-cancer-schizophrenia-and-ischemic-heart-disease-while-some-variations-may-be-seen-for-pneumonia-and-multiple-sclerosis">No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis&lt;/h4>
&lt;p>Dermato Endocrinology: Volume 5, Issue 2 April/May/June 2013&lt;/p>
&lt;p>Susanna við Streym, Lars Rejnmark, Leif Mosekilde and Peter Vestergaard&lt;/p></description></item><item><title>More hijab clothing may have resulted in 6X increase in Multiple Sclerosis in Tehran</title><link>/posts/more-hijab-clothing-may-have-resulted-in-6x-increase-in-multiple-sclerosis-in-tehran.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/more-hijab-clothing-may-have-resulted-in-6x-increase-in-multiple-sclerosis-in-tehran.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#what-is-causing-irans-spike-in-ms-cases">What is Causing Iran’s Spike in MS Cases?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="what-is-causing-irans-spike-in-ms-cases">What is Causing Iran’s Spike in MS Cases?&lt;/h4>
&lt;p>Vitamin D deficiency from lack of sunlight could be an unexpected long-term consequence of the Iranian revolution &lt;/p>
&lt;p>By Libby Copeland, Smithsonian magazine, May 2013&lt;/p>
&lt;p>Scientists have long recognized a link between lack of sunlight and multiple sclerosis.&lt;/p>
&lt;p>Multiple sclerosis has skyrocketed in Tehran, increasing almost sevenfold between 1989 and 2005. In Iran’s central province of Isfahan, the incidence nearly tripled from 2005 to 2009. Now Oxford University researchers suggest, for the first time, that the 1979 Iranian Revolution may deserve some of the blame for the extraordinary jump. They say the revolutionary mandate for modest dress and head coverings for women may have inadvertently fueled the increase by limiting their exposure to sunlight.&lt;/p></description></item><item><title>Multiple Sclerosis: high incidence in black women than whites (perhaps vitamin D)</title><link>/posts/multiple-sclerosis-high-incidence-in-black-women-than-whites-perhaps-vitamin-d.html</link><pubDate>Sun, 12 May 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-high-incidence-in-black-women-than-whites-perhaps-vitamin-d.html</guid><description>&lt;h2 id="incidence-of-multiple-sclerosis-in-multiple-racial-and-ethnic-groups">Incidence of multiple sclerosis in multiple racial and ethnic groups.&lt;/h2>
&lt;p>Neurology. 2013 May 7;80(19):1734-9. &lt;a href="https://doi.org/10.1212/WNL.0b013e3182918cc2.">doi: 10.1212/WNL.0b013e3182918cc2.&lt;/a>&lt;/p>
&lt;p>Langer-Gould A, Brara SM, Beaber BE, Zhang JL.&lt;/p>
&lt;p>From the Department of Research and Evaluation (A.L.-G., J.L.Z.), Kaiser Permanente, Southern California, Pasadena; and Neurology Department (A.L.-G., S.M.B., B.E.B.), Kaiser Permanente, Southern California Los Angeles Medical Center, CA.&lt;/p>
&lt;p>OBJECTIVE: To determine whether the incidence of multiple sclerosis (MS) varies by race/ethnicity in a multiethnic, population-based cohort.&lt;/p></description></item><item><title>Vitamin D and multiple sclerosis (technical, outline only)</title><link>/posts/vitamin-d-and-multiple-sclerosis-technical-outline-only.html</link><pubDate>Thu, 25 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-multiple-sclerosis-technical-outline-only.html</guid><description>&lt;p>Journal of Clinical Neuroscience; Available online 26 March 2013&lt;/p>
&lt;p>Sarah Hewer a,&lt;/p>
&lt;p>Robyn Lucas b,&lt;/p>
&lt;p>Ingrid van der Mei c,&lt;/p>
&lt;p>Bruce V. Taylor c, &lt;a href="mailto:bruce.taylor@utas.edu.au">bruce.taylor@utas.edu.au&lt;/a>&lt;/p>
&lt;p>a Royal Hobart Hospital, Department of Neurology, Hobart, Tasmania, Australia&lt;/p>
&lt;p>b National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia&lt;/p>
&lt;p>c Menzies Research Institute Tasmania, University of Tasmania, Locked Bag 23, Hobart, Tasmania 7000, Australia&lt;/p>
&lt;p>The role of vitamin D supplementation in preventing multiple sclerosis (MS) and/or treating MS progression is an area of significant research interest. We detail the current status of the ongoing research in this field, and note the lack of class 1 evidence from well-conducted, large, double-blind, placebo-controlled studies of vitamin D supplementation in the prevention and/or treatment of MS. We have been able to &lt;strong>provide some guidelines for practitioners&lt;/strong> based on the substantial burden of supportive evidence for the use of vitamin D in MS as summarised here. These guidelines may provide some support to those clinicians who treat people with MS and their families.&lt;/p></description></item><item><title>Appears that Vitamin D can induce remission in recent Multiple Sclerosis</title><link>/posts/appears-that-vitamin-d-can-induce-remission-in-recent-multiple-sclerosis.html</link><pubDate>Fri, 19 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/appears-that-vitamin-d-can-induce-remission-in-recent-multiple-sclerosis.html</guid><description>&lt;h3 id="a-hrefpostsdr-coimbra-in-brazil-stylecolor-red-text-decoration-underline-titlethis-link-has-an-unknown-page_id-3857dr-coimbra-in-brazila">&lt;a href="/posts/dr-coimbra-in-brazil" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 3857">Dr. Coimbra, in Brazil&lt;/a>,&lt;/h3>
&lt;p>&lt;strong>Has found that large doses of vitamin D: 20,000 to 150,000 IU/day results in remission of recent cases of Multiple Sclerosis.&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Specifically: Recent lesions appeared partially repaired or disappeared on MRI scans after one and two years of treatment.&lt;/strong>&lt;/p>
&lt;hr>
&lt;h2 id="biomarkers-in-multiple-sclerosis-an-up-to-date-overview-jan-2013">Biomarkers in Multiple Sclerosis: An Up-to-Date Overview Jan 2013&lt;/h2>
&lt;p>&lt;strong>Shows that MRI is one of many MS biomarkers&lt;/strong>&lt;/p></description></item><item><title>Prevention with vitamin D in Multiple Sclerosis is logical – editorial</title><link>/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial.html</link><pubDate>Thu, 04 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/prevention-with-vitamin-d-in-multiple-sclerosis-is-logical-editorial.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-timing-of-sampling-treatment-and-prevention">Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.&lt;/h4>
&lt;p>Biomark Med. 2013 Apr;7(2):193-5. &lt;a href="https://doi.org/10.2217/bmm.13.10.">doi: 10.2217/bmm.13.10.&lt;/a> PMID: 23547812&lt;/p>
&lt;p>Sundström P, Salzer J.&lt;/p>
&lt;p>Department of Pharmacology &amp;amp; Clinical Neuroscience, Section of Neurology, Umeå University, 901 87 Umeå, Sweden. &lt;a href="mailto:peter.sundstrom@neuro.umu.se">peter.sundstrom@neuro.umu.se&lt;/a>.&lt;/p>
&lt;p>With today&amp;rsquo;s knowledge, it is the authors&amp;rsquo; view that enough scientific data exist to suggest that multiple sclerosis patients should be informed about the association between vitamin D levels and multiple sclerosis inflammatory disease activity&lt;/p></description></item><item><title>Multiple sclerosis associated with sun, not low vitamin D</title><link>/posts/multiple-sclerosis-associated-with-sun-not-low-vitamin-d.html</link><pubDate>Sun, 31 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-associated-with-sun-not-low-vitamin-d.html</guid><description>&lt;h2 id="interdependence-and-contributions-of-sun-exposure-and-vitamin-d-to-mri-measures-in-multiple-sclerosis">Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.&lt;/h2>
&lt;p>J Neurol Neurosurg Psychiatry. 2013 Feb 5.&lt;/p>
&lt;p>Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O&amp;rsquo;Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.&lt;/p>
&lt;p>Department of Neurology, Buffalo Neuroimaging Analysis Center, State University of New York, , Buffalo, New York, USA.&lt;/p>
&lt;p>PURPOSE: To assess the relationships of sun exposure history, supplementation and environmental factors to vitamin D levels in multiple sclerosis (MS) patients and to evaluate the associations between sun exposure and MRI measures.&lt;/p></description></item><item><title>Autoimmune disorder patients in Brazil helped by vitamin D – video and Facebook</title><link>/posts/autoimmune-disorder-patients-in-brazil-helped-by-vitamin-d-video-and-facebook.html</link><pubDate>Mon, 04 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/autoimmune-disorder-patients-in-brazil-helped-by-vitamin-d-video-and-facebook.html</guid><description>&lt;h3 id="neat-social-media-spreads-the-word-of-the-benefits-of-vitamin-d3-and-vitamin-k2">Neat: Social media spreads the word of the benefits of Vitamin D3 (and Vitamin K2)&lt;/h3>
&lt;p>&lt;strong>Large doses: 20,000 to 150,000 IU/d&lt;/strong>&lt;/p>
&lt;p>The dose sizes are far larger than what what others are using to prevent MS, but this size is being used to TREAT MS.&lt;/p>
&lt;h3 id="facebook-page-by-the-patientshttpswwwfacebookcomgroups528624870516079-in-portuguese">&lt;a href="https://www.facebook.com/groups/528624870516079/">Facebook Page by the patients&lt;/a> in Portuguese&lt;/h3>
&lt;p>15,800 members as of Nov 2015&lt;/p>
&lt;h3 id="youtube-interview-of-the-doctorhttpwwwyoutubecomwatchvciwiwim4hnm">&lt;a href="http://www.youtube.com/watch?v=cIwIWim4hNM">YouTube interview of the doctor&lt;/a>&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/brazil.jpg" alt="image">
&lt;h3 id="youtube-videohttpwwwyoutubecomwatchveragu1xcy-u-in-portuguese-with-english-and-spanish-subtitles">&lt;a href="http://www.youtube.com/watch?v=erAgu1XcY-U">YouTube Video&lt;/a> In Portuguese with English and Spanish subtitles&lt;/h3>
&lt;p>The documentary was made by Daniel Cunha, a Brazilian journalist.&lt;/p></description></item><item><title>Small increase in Vitamin A metabolites cut new multiple sclerosis lesions in half</title><link>/posts/small-increase-in-vitamin-a-metabolites-cut-new-multiple-sclerosis-lesions-in-half.html</link><pubDate>Thu, 14 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/small-increase-in-vitamin-a-metabolites-cut-new-multiple-sclerosis-lesions-in-half.html</guid><description>&lt;h1 id="vitamin-a-yet-another-player-in-multiple-sclerosis-pathogenesis">Vitamin A: yet another player in multiple sclerosis pathogenesis?&lt;/h1>
&lt;p>Expert Review of Clinical Immunology February 2013, Vol. 9, No. 2, Pages 113-115 , DOI 10.1586/eci.12.105&lt;/p>
&lt;p>Massimo Filippi*, Paolo Preziosa and Maria A Rocca&lt;/p>
&lt;p>Evaluation of: Løken-Amsrud KI, Myhr KM, Bakke SJ et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult. Scler. doi:10.1177/1352458512457843 (2012) (Epub ahead of print).&lt;/p>
&lt;p>A combination of genetic and environmental factors probably plays a role in determining an increased susceptibility to multiple sclerosis (MS). Among these factors, vitamin D and A metabolites are likely to play a role given their immunomodulatory properties. Decreased serum vitamin D levels have been associated with clinical and MRI activity of MS. Løken-Amsrud et al. evaluated the association of retinol concentration with clinical and MRI measures of disease activity in MS patients over a 2-year period. Serum retinol levels correlated with MRI metrics of disease activity, but not with clinical findings. Following IFN-β-1a treatment, the association with MRI metrics was lost. These results support a role of vitamin A metabolites in influencing disease activity in MS.&lt;/p></description></item><item><title>Vitamin D: one sided debate is published in Multiple Sclerosis Journal</title><link>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</link><pubDate>Thu, 07 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-one-sided-debate-is-published-in-multiple-sclerosis-journal.html</guid><description>&lt;h2 id="if-i-had-a-clinically-isolated-syndrome-with-mri-diagnostic-of-ms-i-would-take-vitamin-d-10000-iu-daily-no">If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: No&lt;/h2>
&lt;p>Mult Scler February 2013 vol. 19 no. 2 140-142&lt;/p>
&lt;p>Caroline Papeix, Catherine Lubetzki&lt;/p>
&lt;p>Université Pierre et Marie Curie AP-HP, France&lt;/p>
&lt;p>Catherine Lubetzki, Department of Neurology, Pitié-Salpêtrière Hospital, 75013 Paris, France. Email: &lt;a href="mailto:catherine.lubetzki@psl.aphp.fr">catherine.lubetzki@psl.aphp.fr&lt;/a>&lt;/p>
&lt;hr>
&lt;h3 id="observation-by-vitamindwiki">Observation by VitaminDWiki&lt;/h3>
&lt;p>We see MS professionals, with a lot a stake to keep the status quo (note the conflict of interest section) valiently state why vitamin D has not yet been absolutely proven, and can never be absolutely proven to help MS (people in the placebo group can get vitamin D from food and sun).&lt;/p></description></item><item><title>Vitamin D associated with reduced T-cell attacks in Multiple Sclerosis</title><link>/posts/vitamin-d-associated-with-reduced-t-cell-attacks-in-multiple-sclerosis.html</link><pubDate>Fri, 01 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-associated-with-reduced-t-cell-attacks-in-multiple-sclerosis.html</guid><description>&lt;h4 id="regulatory-role-of-vitamin-d-in-t-cell-reactivity-against-myelin-peptides-in-relapsing-remitting-multiple-sclerosis-patients">Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.&lt;/h4>
&lt;p>MC Neurol. 2012 Sep 24;12:103. &lt;a href="https://doi.org/10.1186/1471-2377-12-103.">doi: 10.1186/1471-2377-12-103.&lt;/a>&lt;/p>
&lt;p>Grau-López L, Granada ML, Raïch-Regué D, Naranjo-Gómez M, Borràs-Serres FE, Martínez-Cáceres E, Ramo-Tello C.&lt;/p>
&lt;p>Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet s/n, Badalona, Barcelona, 08916, Spain. &lt;a href="mailto:laiagrlo@gmail.com">laiagrlo@gmail.com&lt;/a>&lt;/p>
&lt;p>BACKGROUND: Low levels of plasma 25-hydroxyvitaminD (25(OH)D) are associated with a higher incidence of multiple sclerosis (MS) due to the immune suppressive properties of vitamin D.The aim of this study was to determine the correlation between plasma 25(OH)D concentrations and clinical and immunological variables in a cohort of multiple sclerosis patients.&lt;/p></description></item><item><title>Bone health not correlated with Vitamin D level in multiple sclerosis – review</title><link>/posts/bone-health-not-correlated-with-vitamin-d-level-in-multiple-sclerosis-review.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/bone-health-not-correlated-with-vitamin-d-level-in-multiple-sclerosis-review.html</guid><description>&lt;h1 id="bone-health-in-multiple-sclerosis">Bone health in multiple sclerosis&lt;/h1>
&lt;p>Osteoporos Int. 2011 Dec;22(12):2935-49. &lt;a href="https://doi.org/10.1007/s00198-011-1644-8.">doi: 10.1007/s00198-011-1644-8.&lt;/a> Epub 2011 May 21.&lt;/p>
&lt;p>Gibson JC, Summers GD.&lt;/p>
&lt;p>Level 2, Department of Rehabilitation Medicine, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3NE, UK. &lt;a href="mailto:jeremy.gibson@nhs.net">jeremy.gibson@nhs.net&lt;/a>&lt;/p>
&lt;p>People who are disabled with multiple sclerosis (MS) may be at increased risk of osteoporosis. This review discusses issues relevant to bone health in MS and makes practical recommendations regarding prevention and screening for osteoporosis and fracture risk in MS. A search of the literature up until 5 April 2011 was performed using key search terms, and articles pertinent to bone health in MS were analysed. Bone mineral density (BMD) is reduced at the lumbar spine, hip and total body in MS, with the degree of reduction being greatest at the hip. A strong relationship exists between the disability level, measured by the Expanded Disability Status Score, and BMD at the lumbar spine and femoral neck, particularly the latter. The rate of loss of BMD also correlates with the level of disability. Pulsed corticosteroids for acute episodes of MS, even with a high cumulative steroid dose, do not significantly affect BMD, but an effect on fracture risk is yet to be elucidated.&lt;/p></description></item><item><title>Late-stage MS associated with protein in spinal cord which blocks vitamin D</title><link>/posts/late-stage-ms-associated-with-protein-in-spinal-cord-which-blocks-vitamin-d.html</link><pubDate>Tue, 29 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/late-stage-ms-associated-with-protein-in-spinal-cord-which-blocks-vitamin-d.html</guid><description>&lt;h2 id="vitamin-d-binding-protein-in-cerebrospinal-fluid-is-associated-with-multiple-sclerosis-progression">Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.&lt;/h2>
&lt;p>Mol Neurobiol. 2013 Jan 22.&lt;/p>
&lt;p>Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, Liu S.&lt;/p>
&lt;p>Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, Shandong, 250012, People&amp;rsquo;s Republic of China.&lt;/p>
&lt;p>Multiple sclerosis is a neurological disorder that presents with symptoms including inflammation, neurodegeneration, and demyelination of the central nervous system (CNS).&lt;/p></description></item><item><title>Vitamin D looks promising to deal with MS – review 2013</title><link>/posts/vitamin-d-looks-promising-to-deal-with-ms-review-2013.html</link><pubDate>Mon, 28 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-looks-promising-to-deal-with-ms-review-2013.html</guid><description>&lt;h1 id="can-we-prevent-or-treat-multiple-sclerosis-by-individualised-vitamin-d-supply">Can we prevent or treat multiple sclerosis by individualised vitamin D supply?&lt;/h1>
&lt;p>EPMA Journal 2013, 4:4 doi:10.1186/1878-5085-4-4. Published: 29 January 2013&lt;/p>
&lt;p>Jan Dörr, Andrea Döring and Friedemann Paul&lt;/p>
&lt;p>Abstract (provisional)&lt;/p>
&lt;p>Apart from its principal role in bone metabolism and calcium homeostasis, vitamin D has been attributed additional effects including an immunomodulatory, anti-inflammatory, and possibly even neuroprotective capacity which implicates a possible role of vitamin D in autoimmune diseases like multiple sclerosis (MS). Indeed, several lines of evidence including epidemiologic, preclinical, and clinical data suggest that reduced vitamin D levels and/or dysregulation of vitamin D homeostasis is a risk factor for the development of multiple sclerosis on the one hand, and that vitamin D serum levels are inversely associated with disease activity and progression on the other hand. However, these data are not undisputable, and many questions regarding the preventive and therapeutic capacity of vitamin D in MS remain to be answered. In particular, available clinical data derived from interventional trials using vitamin D supplementation as a therapeutic approach in MS are inconclusive and partly contradictory. In this review, we summarise and critically evaluate the existing data on the possible link between vitamin D and multiple sclerosis in light of the crucial question whether optimization of vitamin D status may impact the risk and/or the course of multiple sclerosis.&lt;/p></description></item><item><title>If low level of Vitamin A then 60 percent less likely to get MS (maybe Vitamin D not blocked)</title><link>/posts/if-low-level-of-vitamin-a-then-60-percent-less-likely-to-get-ms-maybe-vitamin-d-not-blocked.html</link><pubDate>Thu, 24 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/if-low-level-of-vitamin-a-then-60-percent-less-likely-to-get-ms-maybe-vitamin-d-not-blocked.html</guid><description>&lt;h4 id="vitamin-a-and-systemic-inflammation-as-protective-factors-in-multiple-sclerosis">Vitamin A and systemic inflammation as protective factors in multiple sclerosis&lt;/h4>
&lt;p>Mult Scler January 18, 2013 1352458512472752&lt;/p>
&lt;p>Jonatan Salzer 1 ; Göran Hallmans 2; Maria Nyström 1; Hans Stenlund 2; Göran Wadell 3; Peter Sundström 1&lt;/p>
&lt;p>1 Department of Pharmacology and Clinical Neuroscience, Section of Neurology at Umeå University, Sweden&lt;/p>
&lt;p>2 Department of Public Health and Clinical Medicine, Umeå University, Sweden&lt;/p>
&lt;p>3 Department of Clinical Microbiology, Umeå University, Sweden&lt;/p>
&lt;p>Jonatan Salzer, Department of Pharmacology and Clinical Neuroscience, Section of Neurology at Umeå University, SE-90187 Umeå, Sweden. Email: &lt;a href="mailto:jonatan.salzer@neuro.umu.se">jonatan.salzer@neuro.umu.se&lt;/a>&lt;/p></description></item><item><title>Vitamin D prevents multiple sclerosis through multiple mechanisms</title><link>/posts/vitamin-d-prevents-multiple-sclerosis-through-multiple-mechanisms.html</link><pubDate>Thu, 24 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-prevents-multiple-sclerosis-through-multiple-mechanisms.html</guid><description>&lt;h4 id="contribution-of-vitamin-d-insufficiency-to-the-pathogenesis-of-multiple-sclerosis">Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis&lt;/h4>
&lt;p>Therapeutic Advances in Neurological Disorders January 23, 2013 1756285612473513&lt;/p>
&lt;p>Charles Pierrot-Deseilligny &lt;a href="mailto:cp.deseilligny@psl.aphp.fr">cp.deseilligny@psl.aphp.fr&lt;/a>, Université Pierre et Marie Curie (Paris VI), Paris, France&lt;/p>
&lt;p>Jean-Claude Souberbielle. Université René Descartes (Paris V), Paris, France&lt;/p>
&lt;p>The contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (MS) is reviewed. Among the multiple recently discovered actions of vitamin D, an immunomodulatory role has been documented in experimental autoimmune encephalomyelitis and in humans.&lt;/p></description></item><item><title>Multiple Sclerosis more likely if mother had less than 25 ng of vitamin D</title><link>/posts/multiple-sclerosis-more-likely-if-mother-had-less-than-25-ng-of-vitamin-d.html</link><pubDate>Sat, 19 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-more-likely-if-mother-had-less-than-25-ng-of-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-as-a-protective-factor-in-multiple-sclerosis">Vitamin D as a protective factor in multiple sclerosis.&lt;/h4>
&lt;p>Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P.&lt;/p>
&lt;p>Neurology. 2012 Nov 20;79(21):2140-5. &lt;a href="https://doi.org/10.1212/WNL.0b013e3182752ea8.">doi: 10.1212/WNL.0b013e3182752ea8.&lt;/a>&lt;/p>
&lt;p>Department of Pharmacology and Clinical Neuroscience, Section of Neurology, Umeå University, Umeå, Sweden. &lt;a href="mailto:jonatan.salzer@neuro.umu.se">jonatan.salzer@neuro.umu.se&lt;/a>&lt;/p>
&lt;p>OBJECTIVE: To examine the association between 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) levels and the risk of multiple sclerosis (MS) in blood samples collected prospectively and during gestation.&lt;/p>
&lt;p>METHODS: In this nested case-control study, 2 population-based biobanks with 291,500 samples from 164,000 persons collected since 1975 in the northern half of Sweden were used. We identified prospectively collected blood samples from MS cases (n = 192, controls matched 2:1) and gestational samples from pregnant mothers where the offspring had later developed MS (n = 37, control mothers matched 5:1). 25(OH)D levels were measured using an ELISA, and the risk of MS was analyzed using matched logistic regression.&lt;/p></description></item><item><title>Multiple Sclerosis and vitamin D – Systematic Review inconclusive</title><link>/posts/multiple-sclerosis-and-vitamin-d-systematic-review-inconclusive.html</link><pubDate>Thu, 10 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-and-vitamin-d-systematic-review-inconclusive.html</guid><description>&lt;h2 id="a-systematic-review-of-randomized-double-blind-placebo-controlled-trials-examining-the-clinical-efficacy-of-vitamin-d-in-multiple-sclerosis">A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis&lt;/h2>
&lt;p>Neuro-epidemiology Vol. 40, No. 3, 2013&lt;/p>
&lt;p>Beatriz Pozuelo-Moyanoa, c, Julián Benito-Leóna –c &lt;a href="mailto:jbenitol@meditex.es">jbenitol@meditex.es&lt;/a>, Alex J. Mitchelld, Jesús Hernández-Gallegoa, c&lt;/p>
&lt;p>A Department of Neurology, University Hospital ‘12 de Octubre’,&lt;/p>
&lt;p>B Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, and&lt;/p>
&lt;p>C Department of Medicine, Complutense University, Madrid, Spain;&lt;/p>
&lt;p>D Department of Psycho-Oncology, Leicestershire Partnership Trust and University of Leicester, Leicester, UK&lt;/p></description></item><item><title>Risk of going from pre-MS to MS reduced 68 percent with 7100 IU vitamin D – RCT</title><link>/posts/risk-of-going-from-pre-ms-to-ms-reduced-68-percent-with-7100-iu-vitamin-d-rct.html</link><pubDate>Thu, 10 Jan 2013 00:00:00 +0000</pubDate><guid>/posts/risk-of-going-from-pre-ms-to-ms-reduced-68-percent-with-7100-iu-vitamin-d-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#preventive-effect-of-vitamin-d3-supplementation-on-conversion-of-optic-neuritis-to-clinically-definite-multiple-sclerosis---a-double-blind-randomized-placebo-controlled-pilot-clinical-trial">Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: - a double blind, randomized, placebo-controlled pilot clinical trial.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#strong-evidence--vitamin-d-prevents-ms-and-reduces-ms-symptoms">Strong evidence: Vitamin D PREVENTS MS and REDUCES MS symptoms&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#85-citations-of-this-study-as-of-june-2024">85 citations of this study as of June 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="preventive-effect-of-vitamin-d3-supplementation-on-conversion-of-optic-neuritis-to-clinically-definite-multiple-sclerosis---a-double-blind-randomized-placebo-controlled-pilot-clinical-trial">Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: - a double blind, randomized, placebo-controlled pilot clinical trial.&lt;/h4>
&lt;p>Acta Neurol Belg. 2012 Dec 19.&lt;/p></description></item><item><title>Vitamin D less than 3000 IU insufficient to reduce MS relapse rate – 5 RCT</title><link>/posts/vitamin-d-less-than-3000-iu-insufficient-to-reduce-ms-relapse-rate-5-rct.html</link><pubDate>Tue, 18 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-less-than-3000-iu-insufficient-to-reduce-ms-relapse-rate-5-rct.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="/posts/overview-ms-and-vitamin-d" style="color: red; text-decoration: underline;" title="This link has an unknown page_id: 691">Overview MS and vitamin D&lt;/a>&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>often 5,000 IU to 10,000 IU&lt;/p>
&lt;/blockquote></description></item><item><title>Vitamin D can both prevent and treat Multiple Sclerosis – review</title><link>/posts/vitamin-d-can-both-prevent-and-treat-multiple-sclerosis-review.html</link><pubDate>Thu, 29 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-can-both-prevent-and-treat-multiple-sclerosis-review.html</guid><description>&lt;h4 id="role-of-vitamin-d-in-the-onset-progression-and-severity-of-multiple-sclerosis">Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.&lt;/h4>
&lt;p>Endocr Pract. 2012 Nov 27:1-22.&lt;/p>
&lt;p>Mesliniene S, Ramrattan L, Giddings S, Sheikh-Ali M.&lt;/p>
&lt;p>Division of Endocrinology, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida.&lt;/p>
&lt;p>Objective: To review and assess the role of vitamin D on the onset, progression and relapse of multiple sclerosis (MS), based on evidence acquired from the analysis of preclinical, observational and interventional studies.&lt;/p></description></item><item><title>Hypothesis of Autoimmunity which includes Epstein-Barr Virus and Vitamin D Deficiency – 2012</title><link>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/hypothesis-of-autoimmunity-which-includes-epstein-barr-virus-and-vitamin-d-deficiency-2012.html</guid><description>&lt;h4 id="cd8-t-cell-deficiency-epstein-barr-virus-infection-vitamin-d-deficiency-and-steps-to-autoimmunity-a-unifying-hypothesis">CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis&lt;/h4>
&lt;p>Autoimmune Diseases, Volume 2012 (2012), Article ID 189096, 16 pages, Review Article&lt;/p>
&lt;p>Michael P. Pender 1,2&lt;/p>
&lt;p>1 School of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia&lt;/p>
&lt;p>2 Department of Neurology, Royal Brisbane and Women&amp;rsquo;s Hospital, Brisbane, QLD 4029, Australia&lt;/p>
&lt;p>Received 18 August 2011; Revised 3 October 2011; Accepted 16 October 2011&lt;/p>
&lt;p>Academic Editor: Corrado Betterle&lt;/p></description></item><item><title>Review of Autoimmune diseases, solar radiation and vitamin D – Schwalfenberg 2012</title><link>/posts/review-of-autoimmune-diseases-solar-radiation-and-vitamin-d-schwalfenberg-2012.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/review-of-autoimmune-diseases-solar-radiation-and-vitamin-d-schwalfenberg-2012.html</guid><description>&lt;h3 id="solar-radiation-and-vitamin-d-mitigating-environmental-factors-in-autoimmune-disease">Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease&lt;/h3>
&lt;p>Journal of Environmental and Public Health, Volume 2012 (2012), Article ID 619381, 9 pages, Review Article&lt;/p>
&lt;p>Gerry K. Schwalfenberg&lt;/p>
&lt;p>Department of Family Medicine, University of Alberta, Suite No. 301, 9509-156 Street, Edmonton, AB, Canada T6G 2M7&lt;/p>
&lt;p>Received 3 July 2011; Revised 29 November 2011; Accepted 13 December 2011&lt;/p>
&lt;p>This paper looks at the environmental role of vitamin D and solar radiation as risk reduction factors in autoimmune disease. Five diseases are considered: multiple sclerosis, type 1 diabetes, rheumatoid arthritis, autoimmune disease of the thyroid, and inflammatory bowel disease. Clinical relevant studies and factors that may indicate evidence that autoimmune disease is a vitamin D-sensitive disease are presented. Studies that have resulted in prevention or amelioration of some autoimmune disease are discussed. An example of the utility of supplementing vitamin D in an unusual autoimmune disease, idiopathic thrombocytic purpura, is presented.&lt;/p></description></item><item><title>Transgeneration vitamin D deficiency related to MS was found in mice</title><link>/posts/transgeneration-vitamin-d-deficiency-related-to-ms-was-found-in-mice.html</link><pubDate>Sun, 25 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/transgeneration-vitamin-d-deficiency-related-to-ms-was-found-in-mice.html</guid><description>&lt;h4 id="prenatal-vitamin-d-deficiency-induces-an-early-and-more-severe-experimental-autoimmune-encephalomyelitis-in-the-second-generation">Prenatal Vitamin D Deficiency Induces an Early and More Severe Experimental Autoimmune Encephalomyelitis in the Second Generation&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2012, 13(9), 10911-10919; doi:10.3390/ijms130910911&lt;/p>
&lt;p>Diana Andrea Fernandes de Abreu 1 , Véréna Landel 1 , Adrian G. Barnett 2 , John McGrath 3,4 , Darryl Eyles 3,4 and Francois Feron 1,*&lt;/p>
&lt;p>1 Neurobiology of Cell Interactions and Neurophysiopathology, Centre National de la Recherche Scientifique, UMR 7259, Aix Marseille Université, Marseille 13015, France&lt;/p></description></item><item><title>Epigenetics, vitamin D, and Multiple Sclerosis</title><link>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</link><pubDate>Wed, 21 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/epigenetics-vitamin-d-and-multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#epigenetics---is-it-real-new-york-times-review-of-plos-genetics-article---july-2016">Epigenetics - is it real: New York Times review of PLOS Genetics article - July 2016&lt;/a>&lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="epigenetic-changes-in-patients-with-multiple-sclerosis---nov-2012">Epigenetic changes in patients with multiple sclerosis - Nov 2012&lt;/h2>
&lt;p>Nat Rev Neurol. 2012 Nov 20. &lt;a href="https://doi.org/10.1038/nrneurol.2012.226.">doi: 10.1038/nrneurol.2012.226.&lt;/a>&lt;/p>
&lt;p>Koch MW, Metz LM, Kovalchuk O.&lt;/p>
&lt;p>Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, 1403-29th Street N. W., Calgary, AB T2N 2T9, Canada.&lt;/p>
&lt;p>Epigenetic changes influence gene expression without altering the DNA sequence. DNA methylation, histone modification and microRNA-associated post-transcriptional gene silencing are three key epigenetic mechanisms. Multiple sclerosis (MS) is a disease of the CNS with both inflammatory and neurodegenerative features. Although studies on epigenetic changes in MS only began in the past decade, a growing body of literature suggests that epigenetic changes may be involved in the development of MS, possibly by mediating the effects of environmental risk factors, such as&lt;/p></description></item><item><title>Multiple Sclerosis</title><link>/posts/multiple-sclerosis.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#ms-associations-with-autoimmune-33-uv-21-genetics-20-intervention-18-parkinson-15-high-dose-15-cognitive-14-pregnancy-11-receptor-10-lupus-9-ra-9-omega-9-virus-9-immunity-7-psoriasis-7-diabetes-6-gut-6-etc">MS associations with: Autoimmune 33; UV 21; Genetics 20; Intervention 18; Parkinson 15; High-Dose 15; Cognitive 14; Pregnancy 11; Receptor 10; Lupus 9; RA 9; Omega 9; Virus 9; Immunity 7; Psoriasis 7; Diabetes 6; Gut 6 etc.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="ms-associations-with-autoimmune-33-uv-21-genetics-20-intervention-18-parkinson-15-high-dose-15-cognitive-14-pregnancy-11-receptor-10-lupus-9-ra-9-omega-9-virus-9-immunity-7-psoriasis-7-diabetes-6-gut-6-etc">MS associations with: Autoimmune 33; UV 21; Genetics 20; Intervention 18; Parkinson 15; High-Dose 15; Cognitive 14; Pregnancy 11; Receptor 10; Lupus 9; RA 9; Omega 9; Virus 9; Immunity 7; Psoriasis 7; Diabetes 6; Gut 6 etc.&lt;/h4></description></item><item><title>Multiple Sclerosis 23 percent more likely if born in April vs. Oct – meta-analysis</title><link>/posts/multiple-sclerosis-23-percent-more-likely-if-born-in-april-vs-oct-meta-analysis.html</link><pubDate>Thu, 15 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-23-percent-more-likely-if-born-in-april-vs-oct-meta-analysis.html</guid><description>&lt;h3 id="the-month-of-birth-effect-in-multiple-sclerosis-systematic-review-meta-analysis-and-effect-of-latitude">The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry doi:10.1136/jnnp-2012-303934&lt;/p>
&lt;p>Ruth Dobson1, Gavin Giovannoni1, Sreeram Ramagopalan1,2,3&lt;/p>
&lt;p>1 Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London UK&lt;/p>
&lt;p>2 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK&lt;/p>
&lt;p>3 Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK&lt;/p>
&lt;p>Correspondence to: Dr Ruth Dobson, Queen Mary University of London, Blizard Institute, Newark Street, London E1 2AT; &lt;a href="mailto:ruth.dobson@qmul.ac.uk">ruth.dobson@qmul.ac.uk&lt;/a>&lt;/p></description></item><item><title>Environmental risk factors for MS include latitude and vitamin D</title><link>/posts/environmental-risk-factors-for-ms-include-latitude-and-vitamin-d.html</link><pubDate>Tue, 13 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/environmental-risk-factors-for-ms-include-latitude-and-vitamin-d.html</guid><description>&lt;h4 id="environmental-risk-factors-for-multiple-sclerosis-a-review-with-a-focus-on-molecular-mechanisms">Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms&lt;/h4>
&lt;p>Int J Mol Sci. 2012; 13(9): 11718–11752.&lt;/p>
&lt;p>Cullen O’Gorman,1,* Robyn Lucas,2 and Bruce Taylor 3&lt;/p>
&lt;p>1 School of Medicine, Griffith University, Gold Coast, Queensland 4222, Australia&lt;/p>
&lt;p>2 National Centre for Epidemiology and Population Health, the Australian National University, Canberra, Australian Capital Territory 0200, Australia; E-Mail: &lt;a href="mailto:robyn.lucas@anu.edu.au">robyn.lucas@anu.edu.au&lt;/a>&lt;/p>
&lt;p>3 Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania 7000, Australia; E-Mail: &lt;a href="mailto:bruce.taylor@utas.edu.au">bruce.taylor@utas.edu.au&lt;/a>&lt;/p></description></item><item><title>Vitamin D enabled a woman with MS to walk long distances again</title><link>/posts/vitamin-d-enabled-a-woman-with-ms-to-walk-long-distances-again.html</link><pubDate>Thu, 01 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-enabled-a-woman-with-ms-to-walk-long-distances-again.html</guid><description>&lt;h1 id="effect-of-high-dose-vitamin-d3-intake-on-ambulation-muscular-pain-and-bone-mineral-density">Effect of High-Dose Vitamin D3 Intake on Ambulation, Muscular Pain and Bone Mineral Density&lt;/h1>
&lt;h2 id="in-a-woman-with-multiple-sclerosis-a-10-year-longitudinal-case-report">in a Woman with Multiple Sclerosis: A 10-Year Longitudinal Case Report&lt;/h2>
&lt;p>Int. J. Mol. Sci. 2012, 13(10), 13461-13483; doi:10.3390/ijms131013461&lt;/p>
&lt;p>Barbara M. van Amerongen 1,2, &lt;a href="mailto:b.m.van.amerongen@inter.nl.net">b.m.van.amerongen@inter.nl.net&lt;/a> and François Feron 3&lt;/p>
&lt;p>1 Department of Molecular Cell Biology and Immunology, VU University Medical Center,1017 MB Amsterdam, The Netherlands&lt;/p>
&lt;p>2 Department of Cariology Endodontology Pedodontology, Academic Centre for Dentistry, 1081 LA Amsterdam, Amsterdam, The Netherlands&lt;/p></description></item><item><title>Less MS (MRI) decline after raising Vitamin D levels – clinical trial</title><link>/posts/less-ms-mri-decline-after-raising-vitamin-d-levels-clinical-trial.html</link><pubDate>Wed, 31 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/less-ms-mri-decline-after-raising-vitamin-d-levels-clinical-trial.html</guid><description>&lt;h4 id="vitamin-d-and-multiple-sclerosis-an-interview-with-ellen-mowryhttpwwwnews-medicalnetnews20121031vitamin-d-and-multiple-sclerosis-an-interview-with-ellen-mowryaspx-news-medicalnet">&lt;a href="http://www.news-medical.net/news/20121031/Vitamin-D-and-multiple-sclerosis-an-interview-with-Ellen-Mowry.aspx">Vitamin D and multiple sclerosis: an interview with Ellen Mowry&lt;/a> news Medical.Net&lt;/h4>
&lt;p>&lt;strong>Excellent interview&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Highlights&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Tracked 469 people with MS for 5 years&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Higher vitamin D was associated with fewer MS spots on MRI the next year.&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h4 id="vitamin-d-status-predicts-new-brain-magnetic-resonance-imaging-activity-in-multiple-sclerosis">Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.&lt;/h4>
&lt;p>Ann Neurol. 2012 Aug;72(2):234-40. &lt;a href="https://doi.org/10.1002/ana.23591.">doi: 10.1002/ana.23591.&lt;/a>&lt;/p>
&lt;p>Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D.&lt;/p></description></item><item><title>Unsaturated Fatty acids important for both MS and Vitamin D</title><link>/posts/unsaturated-fatty-acids-important-for-both-ms-and-vitamin-d.html</link><pubDate>Wed, 31 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/unsaturated-fatty-acids-important-for-both-ms-and-vitamin-d.html</guid><description/></item><item><title>Multiple Sclerosis not helped with half a microgram of calcitriol – 2012</title><link>/posts/multiple-sclerosis-not-helped-with-half-a-microgram-of-calcitriol-2012.html</link><pubDate>Sat, 27 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-not-helped-with-half-a-microgram-of-calcitriol-2012.html</guid><description>&lt;h4 id="effects-of-adjunct-low-dose-vitamin-d-on-relapsing-remitting-multiple-sclerosis-progression-preliminary-findings-of-a-randomized-placebo-controlled-trial">Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: !!Preliminary Findings of a Randomized Placebo-Controlled Trial&lt;/h4>
&lt;p>Multiple Sclerosis International, Volume 2012 (2012), Article ID 452541, 7 pages&lt;/p>
&lt;p>Vahid Shaygannejad,1 Mohsen Janghorbani,2 Fereshteh Ashtari,1 and Hamed Dehghan1&lt;/p>
&lt;p>1 Department of Neurology, Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan 8144503500, Iran&lt;/p>
&lt;p>2 Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan 8144503500, Iran&lt;/p></description></item><item><title>Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran</title><link>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</link><pubDate>Mon, 15 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/is-the-iranian-revolution-to-blame-for-the-increasing-incidence-of-multiple-sclerosis-in-iran.html</guid><description>&lt;p>There are two items on this page&lt;/p>
&lt;hr>
&lt;h3 id="multiple-sclerosis-and-the-iranian-revolution">MULTIPLE SCLEROSIS AND THE IRANIAN REVOLUTION&lt;/h3>
&lt;p>J Neurol Neurosurg Psychiatry 2013;84:e2 doi:10.1136/jnnp-2013-306573.185&lt;/p>
&lt;p>Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013&lt;/p>
&lt;p>Julia Pakpoor⇓,&lt;/p>
&lt;p>Sreeram Ramagopalan&lt;/p>
&lt;p>University of Oxford; Barts and the London School of Medicine and Dentistry&lt;/p>
&lt;p>Multiple Sclerosis (MS) is a complex neurological disorder most likely caused by gene–environment interactions. There is a latitudinal gradient of MS prevalence and vitamin D deficiency has been strongly implicated in MS aetiology. Iran is a country of high levels of sunshine which has previously been considered a low–risk MS region. However, Iran has recently observed an &lt;strong>&lt;span style="color:#F00;">8.3–fold rise in the incidence of MS between 1989–2006&lt;/span>.&lt;/strong> 1 Previous studies have indicated a genetic predisposition to MS in the Iranian population but genetic changes are unlikely to account for the substantial rise in MS over the last few decades. Thus, we aimed to develop a novel hypothesis to explain the identification of Iran as a high–risk MS region. We believe that the influence of decreased sunshine exposure and vitamin D levels on MS risk needs to be strongly considered in the context of Iran&amp;rsquo;s history. In 1979 the Iranian Revolution took place and a country previously under great Western influences became an Islamic republic. It became a government requirement for women to wear loose–fitting clothing and the veil in public; it has previously been shown that veiled women have lower vitamin D levels compared to unveiled women. This significant cultural shift would not only potentially explain the observed increase in MS but notably, it would account for the increasing female preponderance of MS in Iran. Given that the average age of MS onset is 30 years old and that MS incidence in Iran just over 30 years following the revolution is the highest so far recorded, an association with the Iranian revolution and reduced subsequent vitamin D levels in particularly pregnant women is likely. Lifestyle changes such as urbanization and use of sunscreen may to some extent have contributed to increased vitamin D deficiency, but these are unlikely to contribute to the particularly high increase in MS observed in Iran as these changes occurred across the developed world and there is no evidence to suggest that they were particularly great in Iran. &lt;strong>A similar high incidence of MS has been observed among Iranian immigrants in countries at high latitude such as Sweden&lt;/strong> where Iranian immigrants have a reported greater prevalence of MS compared to the general population, &lt;strong>despite wearing a veil not being a requirement.&lt;/strong> Instead it is well–known that UVB exposure is lower in countries at high latitude and thus, a similar effect of increased MS incidence due to vitamin D deficiency may be observed among those in Iran wearing the veil and those resident in countries at high latitude, even if they are not wearing the veil. Therefore, vitamin D repletion is a critical public health issue for Iranians both within and outside Iran, and could help prevent an emerging MS epidemic in this population. More generally, this region is highly interesting for MS research and highlights that regions of exception to the latitudinal gradient of MS prevalence are an under–appreciated and very useful resource in evaluating MS aetiology.&lt;/p></description></item><item><title>MS helped by average daily 2800 IU vitamin D – RCT</title><link>/posts/ms-helped-by-average-daily-2800-iu-vitamin-d-rct.html</link><pubDate>Sat, 25 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/ms-helped-by-average-daily-2800-iu-vitamin-d-rct.html</guid><description/></item><item><title>Neurology J. had 4 items on Multiple Sclerosis and Vitamin D – review by MS Soc</title><link>/posts/neurology-j-had-4-items-on-multiple-sclerosis-and-vitamin-d-review-by-ms-soc.html</link><pubDate>Thu, 16 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/neurology-j-had-4-items-on-multiple-sclerosis-and-vitamin-d-review-by-ms-soc.html</guid><description/></item><item><title>2900 IU of vitamin D (20000 weekly) kept levels above 20 ng during the winter</title><link>/posts/2900-iu-of-vitamin-d-20000-weekly-kept-levels-above-20-ng-during-the-winter.html</link><pubDate>Thu, 02 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/2900-iu-of-vitamin-d-20000-weekly-kept-levels-above-20-ng-during-the-winter.html</guid><description>&lt;h4 id="what-is-needed-to-keep-persons-with-multiple-sclerosis-vitamin-d-sufficient-throughout-the-year">What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?&lt;/h4>
&lt;p>J Neurol. 2012 Aug 1.&lt;/p>
&lt;p>Steffensen LH, Brustad M, Kampman MT.&lt;/p>
&lt;p>Department of Neurology, University Hospital of North Norway, P.O. Box 33, 9038, Tromsø, Norway, &lt;a href="mailto:linn.hofsoy.steffensen@unn.no">linn.hofsoy.steffensen@unn.no&lt;/a>.&lt;/p>
&lt;p>Vitamin D sufficiency has been associated with lower risk of multiple sclerosis and may also have a favorable effect on the course of the disease.&lt;/p>
&lt;p>The aim of this work was to identify predictors of serum 25-hydroxy vitamin D (25&lt;span>[OH]&lt;/span>D) levels in persons with multiple sclerosis (MS) and to assess the effect of high-dose vitamin D(3) supplementation on vitamin D status.&lt;/p></description></item><item><title>3X more vitamin D from the sun if take MS drug Interferon-β</title><link>/posts/3x-more-vitamin-d-from-the-sun-if-take-ms-drug-interferon.html</link><pubDate>Fri, 27 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/3x-more-vitamin-d-from-the-sun-if-take-ms-drug-interferon.html</guid><description/></item><item><title>Multiple Sclerosis not affected by 2800 IU of vitamin D</title><link>/posts/multiple-sclerosis-not-affected-by-2800-iu-of-vitamin-d.html</link><pubDate>Thu, 19 Jul 2012 00:00:00 +0000</pubDate><guid>/posts/multiple-sclerosis-not-affected-by-2800-iu-of-vitamin-d.html</guid><description/></item></channel></rss>